KR20140121344A - Catalyst for olefin polymerization and method for preparing polyolefin using the same - Google Patents
Catalyst for olefin polymerization and method for preparing polyolefin using the same Download PDFInfo
- Publication number
- KR20140121344A KR20140121344A KR20140034293A KR20140034293A KR20140121344A KR 20140121344 A KR20140121344 A KR 20140121344A KR 20140034293 A KR20140034293 A KR 20140034293A KR 20140034293 A KR20140034293 A KR 20140034293A KR 20140121344 A KR20140121344 A KR 20140121344A
- Authority
- KR
- South Korea
- Prior art keywords
- carbon atoms
- compound
- formula
- group
- catalyst
- Prior art date
Links
- 239000003054 catalyst Substances 0.000 title claims abstract description 45
- 238000000034 method Methods 0.000 title claims abstract description 28
- 238000006116 polymerization reaction Methods 0.000 title claims abstract description 26
- 150000001336 alkenes Chemical class 0.000 title claims abstract description 24
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 229920000098 polyolefin Polymers 0.000 title claims abstract description 19
- 150000003623 transition metal compounds Chemical class 0.000 claims abstract description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 78
- 150000001875 compounds Chemical class 0.000 claims description 55
- -1 cationic Lewis base Chemical class 0.000 claims description 17
- 239000000178 monomer Substances 0.000 claims description 12
- 229910052736 halogen Inorganic materials 0.000 claims description 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 125000001424 substituent group Chemical group 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 150000001925 cycloalkenes Chemical class 0.000 claims description 7
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 239000004711 α-olefin Substances 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 239000010936 titanium Substances 0.000 claims description 6
- 125000004104 aryloxy group Chemical group 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 239000003426 co-catalyst Substances 0.000 claims description 5
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 claims description 5
- 239000003446 ligand Substances 0.000 claims description 5
- 229910052723 transition metal Inorganic materials 0.000 claims description 5
- 150000003624 transition metals Chemical class 0.000 claims description 5
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052796 boron Inorganic materials 0.000 claims description 4
- 150000001993 dienes Chemical class 0.000 claims description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 230000000379 polymerizing effect Effects 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical group [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000005055 alkyl alkoxy group Chemical group 0.000 claims description 3
- 125000001118 alkylidene group Chemical group 0.000 claims description 3
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 125000005018 aryl alkenyl group Chemical group 0.000 claims description 3
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 229910052735 hafnium Inorganic materials 0.000 claims description 3
- VBJZVLUMGGDVMO-UHFFFAOYSA-N hafnium atom Chemical compound [Hf] VBJZVLUMGGDVMO-UHFFFAOYSA-N 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- VSZWPYCFIRKVQL-UHFFFAOYSA-N selanylidenegallium;selenium Chemical compound [Se].[Se]=[Ga].[Se]=[Ga] VSZWPYCFIRKVQL-UHFFFAOYSA-N 0.000 claims description 3
- 229910052719 titanium Inorganic materials 0.000 claims description 3
- 239000007848 Bronsted acid Substances 0.000 claims description 2
- 239000002879 Lewis base Substances 0.000 claims description 2
- 229910052795 boron group element Inorganic materials 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 claims description 2
- 230000001976 improved effect Effects 0.000 abstract description 9
- 238000003780 insertion Methods 0.000 abstract description 2
- 230000037431 insertion Effects 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 description 42
- 238000003786 synthesis reaction Methods 0.000 description 42
- 238000005481 NMR spectroscopy Methods 0.000 description 32
- 239000000243 solution Substances 0.000 description 24
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 22
- 239000002904 solvent Substances 0.000 description 20
- 230000000052 comparative effect Effects 0.000 description 19
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 18
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 16
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 239000007787 solid Substances 0.000 description 15
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 14
- 238000004009 13C{1H}-NMR spectroscopy Methods 0.000 description 13
- 238000007334 copolymerization reaction Methods 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 11
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 11
- 229920001577 copolymer Polymers 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 8
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 7
- 229910004298 SiO 2 Inorganic materials 0.000 description 7
- 235000011089 carbon dioxide Nutrition 0.000 description 7
- 229940125758 compound 15 Drugs 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- 235000019198 oils Nutrition 0.000 description 7
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 6
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 6
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 6
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 6
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 6
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 6
- 229940125797 compound 12 Drugs 0.000 description 6
- 229940126543 compound 14 Drugs 0.000 description 6
- 229940125833 compound 23 Drugs 0.000 description 6
- 229940126214 compound 3 Drugs 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 6
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 5
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 5
- QJQNTXCURBPBOK-UHFFFAOYSA-N 2,3,4-trimethylcyclopent-2-en-1-one Chemical compound CC1CC(=O)C(C)=C1C QJQNTXCURBPBOK-UHFFFAOYSA-N 0.000 description 5
- 229940126657 Compound 17 Drugs 0.000 description 5
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 5
- 239000005977 Ethylene Substances 0.000 description 5
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 5
- 229940125782 compound 2 Drugs 0.000 description 5
- 229940126208 compound 22 Drugs 0.000 description 5
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 4
- 229940125773 compound 10 Drugs 0.000 description 4
- 229940126086 compound 21 Drugs 0.000 description 4
- 229940125898 compound 5 Drugs 0.000 description 4
- HEAMQYHBJQWOSS-UHFFFAOYSA-N ethene;oct-1-ene Chemical compound C=C.CCCCCCC=C HEAMQYHBJQWOSS-UHFFFAOYSA-N 0.000 description 4
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 4
- 229910052744 lithium Inorganic materials 0.000 description 4
- 239000012044 organic layer Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229910021607 Silver chloride Inorganic materials 0.000 description 3
- 229910010413 TiO 2 Inorganic materials 0.000 description 3
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 229940126142 compound 16 Drugs 0.000 description 3
- 229940125810 compound 20 Drugs 0.000 description 3
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- RIHHDNYCTKOKAZ-UHFFFAOYSA-M magnesium;methylsulfanylbenzene;bromide Chemical compound [Mg+2].[Br-].CSC1=CC=[C-]C=C1 RIHHDNYCTKOKAZ-UHFFFAOYSA-M 0.000 description 3
- OFDIPUNYMRLSER-UHFFFAOYSA-M magnesium;n,n-dimethylaniline;bromide Chemical compound [Mg+2].[Br-].CN(C)C1=CC=[C-]C=C1 OFDIPUNYMRLSER-UHFFFAOYSA-M 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 2
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 235000019502 Orange oil Nutrition 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical compound C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentene Chemical compound C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methylcyclopentane Chemical compound CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 2
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003440 styrenes Chemical class 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- UVNPEUJXKZFWSJ-LMTQTHQJSA-N (R)-N-[(4S)-8-[6-amino-5-[(3,3-difluoro-2-oxo-1H-pyrrolo[2,3-b]pyridin-4-yl)sulfanyl]pyrazin-2-yl]-2-oxa-8-azaspiro[4.5]decan-4-yl]-2-methylpropane-2-sulfinamide Chemical compound CC(C)(C)[S@@](=O)N[C@@H]1COCC11CCN(CC1)c1cnc(Sc2ccnc3NC(=O)C(F)(F)c23)c(N)n1 UVNPEUJXKZFWSJ-LMTQTHQJSA-N 0.000 description 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- VNPQQEYMXYCAEZ-UHFFFAOYSA-N 1,2,3,4-tetramethylcyclopenta-1,3-diene Chemical compound CC1=C(C)C(C)=C(C)C1 VNPQQEYMXYCAEZ-UHFFFAOYSA-N 0.000 description 1
- RELMFMZEBKVZJC-UHFFFAOYSA-N 1,2,3-trichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1Cl RELMFMZEBKVZJC-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- NUGPIZCTELGDOS-QHCPKHFHSA-N N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclopentanecarboxamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CC[C@@H](C=1C=NC=CC=1)NC(=O)C1CCCC1)C NUGPIZCTELGDOS-QHCPKHFHSA-N 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 239000011954 Ziegler–Natta catalyst Substances 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 229910001570 bauxite Inorganic materials 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- HRYZWHHZPQKTII-UHFFFAOYSA-N chloroethane Chemical compound CCCl HRYZWHHZPQKTII-UHFFFAOYSA-N 0.000 description 1
- 229960001701 chloroform Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 229960003750 ethyl chloride Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- HTJPDOPKPWUNBX-UHFFFAOYSA-M magnesium;2h-thiophen-2-ide;bromide Chemical compound [Mg+2].[Br-].C=1C=[C-]SC=1 HTJPDOPKPWUNBX-UHFFFAOYSA-M 0.000 description 1
- BRKADVNLTRCLOW-UHFFFAOYSA-M magnesium;fluorobenzene;bromide Chemical compound [Mg+2].[Br-].FC1=CC=[C-]C=C1 BRKADVNLTRCLOW-UHFFFAOYSA-M 0.000 description 1
- RBWRWAUAVRMBAC-UHFFFAOYSA-M magnesium;methoxybenzene;bromide Chemical compound [Mg+2].[Br-].COC1=CC=[C-]C=C1 RBWRWAUAVRMBAC-UHFFFAOYSA-M 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012968 metallocene catalyst Substances 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- ZCYXXKJEDCHMGH-UHFFFAOYSA-N nonane Chemical compound CCCC[CH]CCCC ZCYXXKJEDCHMGH-UHFFFAOYSA-N 0.000 description 1
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 1
- QYZLKGVUSQXAMU-UHFFFAOYSA-N penta-1,4-diene Chemical compound C=CCC=C QYZLKGVUSQXAMU-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F4/00—Polymerisation catalysts
- C08F4/42—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors
- C08F4/44—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides
- C08F4/60—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides together with refractory metals, iron group metals, platinum group metals, manganese, rhenium technetium or compounds thereof
- C08F4/62—Refractory metals or compounds thereof
- C08F4/64—Titanium, zirconium, hafnium or compounds thereof
- C08F4/65—Pretreating the metal or compound covered by group C08F4/64 before the final contacting with the metal or compound covered by group C08F4/44
- C08F4/652—Pretreating with metals or metal-containing compounds
- C08F4/656—Pretreating with metals or metal-containing compounds with silicon or compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F10/00—Homopolymers and copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F210/00—Copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond
- C08F210/04—Monomers containing three or four carbon atoms
- C08F210/08—Butenes
- C08F210/10—Isobutene
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F4/00—Polymerisation catalysts
- C08F4/02—Carriers therefor
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F4/00—Polymerisation catalysts
- C08F4/42—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors
- C08F4/44—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides
- C08F4/60—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides together with refractory metals, iron group metals, platinum group metals, manganese, rhenium technetium or compounds thereof
- C08F4/62—Refractory metals or compounds thereof
- C08F4/64—Titanium, zirconium, hafnium or compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F4/00—Polymerisation catalysts
- C08F4/42—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors
- C08F4/44—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides
- C08F4/60—Metals; Metal hydrides; Metallo-organic compounds; Use thereof as catalyst precursors selected from light metals, zinc, cadmium, mercury, copper, silver, gold, boron, gallium, indium, thallium, rare earths or actinides together with refractory metals, iron group metals, platinum group metals, manganese, rhenium technetium or compounds thereof
- C08F4/62—Refractory metals or compounds thereof
- C08F4/64—Titanium, zirconium, hafnium or compounds thereof
- C08F4/659—Component covered by group C08F4/64 containing a transition metal-carbon bond
- C08F4/6592—Component covered by group C08F4/64 containing a transition metal-carbon bond containing at least one cyclopentadienyl ring, condensed or not, e.g. an indenyl or a fluorenyl ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Abstract
Description
본 발명은 올레핀 중합용 촉매 및 이를 사용한 폴리올레핀의 제조 방법에 관한 것이다.The present invention relates to a catalyst for olefin polymerization and a process for producing a polyolefin using the same.
메탈로센 촉매계는 에틸렌과 다른 알파-올레핀과의 공중합에 매우 유용한 촉매계로 알려져 있으며, 이러한 공중합에 사용되고 있는 공단량체로는 1-부텐(1-butene), 1-헥센(1-hexene), 그리고 1-옥텐(1-octene) 등이 있다. The metallocene catalyst system is known as a catalyst system which is very useful for the copolymerization of ethylene with other alpha-olefins. Examples of the comonomers used in this copolymerization include 1-butene, 1-hexene, 1-octene, and the like.
특히 지글러 나타 촉매의 활성 향상과 더불어, Dow사의 Constrained-Geometry Catlyst(CGC) 등 다양한 종류의 단일 활성점 촉매를 사용한 폴리올레핀의 개발이 이루어지고 있다.In particular, along with the improvement of the activity of the Ziegler-Natta catalyst, the development of polyolefins using a variety of single-site catalysts such as Dow's Constrained-Geometry Catlyst (CGC) is under development.
상기 CGC는 높은 중합 온도에서도 우수한 활성도를 나타내면서 고분자량의 중합체 생성을 가능케 하며, 1-헥센 또는 1-옥텐과 같은 입체적 장애가 큰 알파-올레핀의 공중합성도 우수한 것으로 알려져 있다.It is known that the CGC exhibits excellent activity even at a high polymerization temperature, permits the production of a polymer having a high molecular weight, and is also excellent in the copolymerization of an alpha-olefin having a large steric hindrance such as 1-hexene or 1-octene.
이와 같이 상기 CGC의 우수성이 알려지면서 이의 유도체를 중합 촉매로 적용하여 보다 향상된 효과를 얻고자 활발한 연구가 이루어지고 있다.As described above, the superiority of the CGC is known, and its derivatives have been actively studied as a polymerization catalyst to obtain more improved effects.
하지만, 지금까지 알려진 화합물들은 그 성능에 비하여 합성 과정의 복잡하고, 또는 공중합 성능 등의 측면에서 향상된 결과를 얻지 못하여 실제 산업 현장에 적용하기 어려운 문제가 있다.However, the compounds known so far have a problem in that they are difficult to apply to practical industrial fields because of the complexity of the synthesis process compared with the performance thereof, or the improved results in terms of copolymerization performance.
이에 본 발명은 보다 향상된 공단량체 삽입능을 가지며, 분자량 분포가 넓고 가공성이 우수한 폴리올레핀의 제조를 가능케 하는 올레핀 중합용 촉매를 제공하기 위한 것이다.Accordingly, the present invention is to provide a catalyst for olefin polymerization, which has improved comonomer incorporation ability and is capable of producing a polyolefin having a broad molecular weight distribution and excellent processability.
또한, 본 발명은 상기 촉매를 이용한 폴리올레핀의 제조 방법을 제공하기 위한 것이다.The present invention also provides a process for producing a polyolefin using the catalyst.
본 발명에 따르면, 하기 화학식 1로 표시되는 전이금속 화합물을 포함하는 올레핀 중합용 촉매가 제공된다: According to the present invention, there is provided a catalyst for olefin polymerization comprising a transition metal compound represented by the following general formula:
[화학식 1][Chemical Formula 1]
상기 화학식 1에서,In Formula 1,
M은 4족 전이금속이고;M is a Group 4 transition metal;
Q1 및 Q2는 각각 독립적으로 할로겐, 탄소수 1 내지 20의 알킬, 탄소수 2 내지 10의 알케닐, 탄소수 7 내지 40의 알킬아릴, 탄소수 7 내지 40의 아릴알킬, 탄소수 6 내지 20의 알릴, 탄소수 1 내지 20의 알킬리덴, 탄소수 2 내지 20의 알킬알콕시, 또는 탄소수 7 내지 40의 아릴알콕시이고;Q 1 and Q 2 are each independently selected from the group consisting of halogen, alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 10 carbon atoms, alkylaryl of 7 to 40 carbon atoms, arylalkyl of 7 to 40 carbon atoms, allyl of 6 to 20 carbon atoms, Alkylidene of 1 to 20 carbon atoms, alkylalkoxy of 2 to 20 carbon atoms, or arylalkoxy of 7 to 40 carbon atoms;
R1, R2 및 R3 은 각각 독립적으로 수소, 탄소수 1 내지 20의 알킬, 탄소수 1 내지 10의 알콕시, 탄소수 6 내지 20의 아릴, 탄소수 6 내지 10의 아릴옥시, 탄소수 2 내지 20의 알케닐, 탄소수 7 내지 40의 알킬아릴, 탄소수 7 내지 40의 아릴알킬, 탄소수 8 내지 40의 아릴알케닐, 또는 탄소수 2 내지 10의 알키닐이고; 상기 R1 및 R2 또는 R2 및 R3 서로 연결되어 고리를 형성할 수 있고;R 1 , R 2 and R 3 are each independently selected from the group consisting of hydrogen, alkyl of 1 to 20 carbon atoms, alkoxy of 1 to 10 carbon atoms, aryl of 6 to 20 carbon atoms, aryloxy of 6 to 10 carbon atoms, , Alkylaryl having 7 to 40 carbon atoms, arylalkyl having 7 to 40 carbon atoms, arylalkenyl having 8 to 40 carbon atoms, or alkynyl having 2 to 10 carbon atoms; R 1 and R 2 or R 2 and R 3 may be connected to each other to form a ring;
A는 하기 화학식 2로 표시되는 군에서 선택된 어느 하나의 치환기이다 (단, 하기 화학식 2에서 '*' 표시 부분은 A와 사이클로펜타디에닐 리간드의 연결부임).A is any one substituent selected from the group consisting of a group represented by the following formula (2), provided that the symbol "*" in the following formula (2) is a linkage of A and a cyclopentadienyl ligand.
[화학식 2](2)
상기 화학식 1에서, 바람직하게는, 상기 M은 티타늄(Ti), 지르코늄(Zr) 또는 하프늄(Hf)이고; 상기 Q1 및 Q2 는 각각 독립적으로 메틸 또는 염소이고; 상기 R1, R2 및 R3 는 각각 독립적으로 수소 또는 메틸일 수 있다.In
그리고, 상기 올레핀 중합용 촉매는 조촉매 화합물을 더욱 포함할 수 있다.The catalyst for olefin polymerization may further contain a cocatalyst compound.
그리고, 상기 올레핀 중합용 촉매는 상기 화학식 1로 표시되는 전이금속 화합물이 담지되는 불활성 담체를 포함할 수 있다.The catalyst for olefin polymerization may include an inert carrier on which the transition metal compound represented by Formula 1 is supported.
한편, 본 발명에 따르면, 촉매의 존재 하에서, 적어도 1 종의 올레핀계 단량체를 중합시키는 단계를 포함하는 폴리올레핀의 제조 방법이 제공된다.On the other hand, according to the present invention, there is provided a process for producing a polyolefin comprising the step of polymerizing at least one olefin-based monomer in the presence of a catalyst.
여기서, 상기 올레핀계 단량체는 탄소수 2 내지 20의 알파-올레핀(α-olefin), 탄소수 1 내지 20의 디올레핀(diolefin), 탄소수 3 내지 20의 사이클로올레핀(cyclo-olefin) 또는 탄소수 3 내지 20의 사이클로디올레핀(cyclo-diolefin)으로 이루어진 군에서 선택된 1종 이상의 화합물일 수 있다.The olefinic monomer may be an α-olefin having 2 to 20 carbon atoms, a diolefin having 1 to 20 carbon atoms, a cyclo-olefin having 3 to 20 carbon atoms, or a cycloolefin having 3 to 20 carbon atoms And cyclo-diolefin. The term " cycloolefin "
그리고, 상기 폴리올레핀은 40,000 내지 1,000,000이고, 분자량 분포(Mw/Mn)가 2 내지 30일 수 있다.The polyolefin may have a molecular weight distribution (Mw / Mn) of 40,000 to 1,000,000 and a molecular weight distribution of 2 to 30.
본 발명에 따른 촉매는 보다 향상된 공단량체 삽입능을 가지며, 분자량 분포가 넓고 가공성이 우수한 폴리올레핀의 제조를 가능케 한다.The catalyst according to the present invention makes it possible to produce a polyolefin having improved comonomer incorporation ability, broad molecular weight distribution and excellent workability.
도 1 내지 도 49는 본 발명의 실시예 및 비교예에 따른 화합물들의 합성을 위한 Scheme과 화합물들에 대한 NMR 스펙트럼이다.1 to 49 are NMR spectra of Scheme and compounds for synthesis of compounds according to Examples and Comparative Examples of the present invention.
이하, 본 발명의 구현 예들에 따른 올레핀 중합용 촉매 및 이를 이용한 폴리올레핀의 제조 방법에 대하여 설명하기로 한다.Hereinafter, a catalyst for olefin polymerization according to embodiments of the present invention and a method for producing a polyolefin using the same will be described.
그에 앞서, 본 명세서에 사용되는 전문 용어는 단지 특정 구현예를 언급하기 위한 것이며, 본 발명을 한정하는 것을 의도하지 않는다. 그리고, 여기서 사용되는 단수 형태들은 문구들이 이와 명백히 반대의 의미를 나타내지 않는 한 복수 형태들도 포함한다. 또한, 본 명세서에서 사용되는 '포함' 또는 '함유'의 의미는 특정 특성, 영역, 정수, 단계, 동작, 요소 또는 성분을 구체화하며, 다른 특정 특성, 영역, 정수, 단계, 동작, 요소, 또는 성분의 부가를 제외시키는 것은 아니다.
Prior to that, the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. And, the singular forms used herein include plural forms unless the phrases expressly have the opposite meaning. Also, as used herein, the meaning of "comprising" or "containing" embodies certain features, areas, integers, steps, acts, elements or components, But does not exclude the addition of components.
한편, 본 발명자들은 올레핀 중합용 촉매에 대한 연구를 거듭하는 과정에서, 기존의 구속 기하 촉매의 사이클로펜타디에닐 리간드에 '헤테로 원자를 포함한 곁사슬을 가지는 아릴기'가 도입된 새로운 구조의 전이금속 화합물을 발견하였다. 그리고, 상기 전이금속 화합물은 특히 올레핀 중합 공정에서 보다 향상된 공중합체 삽입능을 나타낼 수 있고, 분자량 분포가 넓고 가공성이 우수한 폴리올레핀의 제조를 가능케 함을 확인하였다.Meanwhile, the inventors of the present invention have found that, in a process of repeatedly studying a catalyst for olefin polymerization, a transition metal compound having a novel structure in which an aryl group having a side chain containing a heteroatom is introduced into a cyclopentadienyl ligand of a conventional constrained geometry catalyst . Further, it has been confirmed that the transition metal compound can exhibit improved copolymer inserting ability particularly in the olefin polymerization process, and can produce a polyolefin having a wide molecular weight distribution and excellent workability.
이와 같은 본 발명의 일 구현 예에 따르면, 하기 화학식 1로 표시되는 전이금속 화합물을 포함하는 올레핀 중합용 촉매가 제공된다:According to one embodiment of the present invention, there is provided a catalyst for olefin polymerization comprising a transition metal compound represented by the following Formula 1:
[화학식 1][Chemical Formula 1]
상기 화학식 1에서,In Formula 1,
M은 4족 전이금속이고;M is a Group 4 transition metal;
Q1 및 Q2는 각각 독립적으로 할로겐, 탄소수 1 내지 20의 알킬, 탄소수 2 내지 10의 알케닐, 탄소수 7 내지 40의 알킬아릴, 탄소수 7 내지 40의 아릴알킬, 탄소수 6 내지 20의 알릴, 탄소수 1 내지 20의 알킬리덴, 탄소수 2 내지 20의 알킬알콕시, 또는 탄소수 7 내지 40의 아릴알콕시이고;Q 1 and Q 2 are each independently selected from the group consisting of halogen, alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 10 carbon atoms, alkylaryl of 7 to 40 carbon atoms, arylalkyl of 7 to 40 carbon atoms, allyl of 6 to 20 carbon atoms, Alkylidene of 1 to 20 carbon atoms, alkylalkoxy of 2 to 20 carbon atoms, or arylalkoxy of 7 to 40 carbon atoms;
R1, R2 및 R3 은 각각 독립적으로 수소, 탄소수 1 내지 20의 알킬, 탄소수 1 내지 10의 알콕시, 탄소수 6 내지 20의 아릴, 탄소수 6 내지 10의 아릴옥시, 탄소수 2 내지 20의 알케닐, 탄소수 7 내지 40의 알킬아릴, 탄소수 7 내지 40의 아릴알킬, 탄소수 8 내지 40의 아릴알케닐, 또는 탄소수 2 내지 10의 알키닐이고; 상기 R1 및 R2 또는 R2 및 R3 서로 연결되어 고리를 형성할 수 있고;R 1 , R 2 and R 3 are each independently selected from the group consisting of hydrogen, alkyl of 1 to 20 carbon atoms, alkoxy of 1 to 10 carbon atoms, aryl of 6 to 20 carbon atoms, aryloxy of 6 to 10 carbon atoms, , Alkylaryl having 7 to 40 carbon atoms, arylalkyl having 7 to 40 carbon atoms, arylalkenyl having 8 to 40 carbon atoms, or alkynyl having 2 to 10 carbon atoms; R 1 and R 2 or R 2 and R 3 may be connected to each other to form a ring;
A는 하기 화학식 2로 표시되는 군에서 선택된 어느 하나의 치환기이다 (단, 하기 화학식 2에서 '*' 표시 부분은 A와 사이클로펜타디에닐 리간드의 연결부임).A is any one substituent selected from the group consisting of a group represented by the following formula (2), provided that the symbol "*" in the following formula (2) is a linkage of A and a cyclopentadienyl ligand.
[화학식 2](2)
상기 화학식 1로 표시되는 전이금속 화합물은 전술한 바와 같이 사이클로펜타디에닐 리간드에 '헤테로 원자를 포함한 곁사슬을 가지는 아릴기' (이하 '화학식 2로 표시되는 군에서 선택되는 1종 이상의 치환기' 또는 '치환기 A'라 한다)가 도입된 새로운 구조를 갖는다. 그에 따라, 상기 화학식 1로 표시되는 화합물은 상기 곁사슬 아릴기가 도입되지 않은 화합물에 비하여 보다 큰 중량평균분자량과 보다 넓은 분자량 분포를 갖는 폴리올레핀의 합성을 가능케 한다. The transition metal compound represented by the above formula (1) may be prepared by reacting a cyclopentadienyl ligand with an aryl group having a side chain containing a heteroatom (hereinafter referred to as' at least one substituent selected from the group represented by the formula (2) Substituent A ') is introduced. Accordingly, the compound represented by the above formula (1) enables the synthesis of a polyolefin having a larger weight average molecular weight and a broader molecular weight distribution than the compound having no side chain aryl group introduced therein.
그리고, 상기 화학식 1로 표시되는 화합물은 올레핀계 단량체와 알파-올레핀의 공중합 공정에서 보다 향상된 공단량체 삽입능을 나타낼 수 있다. 즉, 동등한 정도의 중량평균분자량을 갖는 공중합체를 기준으로 할 때, 상기 화학식 1로 표시되는 화합물을 촉매로 이용하여 얻어진 공중합체는 기존의 촉매를 이용하여 얻어진 공중합체에 비하여 보다 높은 공단량체의 함량을 나타낼 수 있다. 그에 따라, 상기 화학식 1로 표시되는 화합물은 이전의 균일계 촉매 또는 비균일계 촉매에서 기대하기 어려웠던 다양한 물성 (즉, 공단량체 함량, 중량평균분자량, 분자량 분포 등의 조절을 통해 달성될 수 있는 다양한 물성)을 갖는 폴리올레핀의 제공을 가능케 한다.
The compound represented by Formula 1 may exhibit improved comonomer insertion capability in the copolymerization process of the olefin monomer and the alpha-olefin. That is, when a copolymer having an equivalent weight average molecular weight is used as a reference, the copolymer obtained by using the compound represented by the formula (1) as a catalyst has a higher comonomer Can be expressed. Accordingly, the compound represented by the above formula (1) has various physical properties (that is, various properties that can be achieved through control of comonomer content, weight average molecular weight, molecular weight distribution, and the like) Physical properties) of the polyolefin.
한편, 일 구현 예에 따르면, 상기 화학식 1로 표시되는 화합물에 있어서, 상기 R1, R2 및 R3 는 각각 독립적으로 아세탈, 케탈 또는 에테르기를 포함하는 치환기로 치환 또는 비치환된 것일 수 있다. 상기 R1, R2 및 R3 가 상기 예시의 치환기로 치환될 경우 담체의 표면에 담지시키는데 보다 유리할 수 있다.According to an embodiment, R 1 , R 2 and R 3 in the compound represented by Formula 1 may be independently substituted or unsubstituted with a substituent including an acetal, ketal or ether group. When R 1 , R 2 and R 3 are substituted with the above-mentioned substituent, they may be more advantageously supported on the surface of the carrier.
또한, 일 구현 예에 따르면, 상기 화학식 1로 표시되는 화합물에 있어서, 상기 M은 티타늄(Ti), 지르코늄(Zr) 또는 하프늄(Hf)인 것이 촉매의 활성 또는 재현 가능성 측면에서 바람직하고; 상기 Q1 및 Q2 는 각각 독립적으로 메틸 또는 염소인 것이 바람직하다. 또한, 상기 R1, R2, 및 R3 는 각각 독립적으로 수소 또는 메틸인 것이 바람직하다. 이와 같은 각각의 치환기는 상기 중심금속(M) 주위의 전자적 및 입체적 환경을 제어하는데 유리하여 보다 높은 활성을 나타낼 수 있어 바람직하다.
According to an embodiment, M is preferably titanium (Ti), zirconium (Zr), or hafnium (Hf) in terms of the activity or reproducibility of the catalyst; The Q 1 and Q 2 Are each independently methyl or chlorine. It is preferable that each of R 1 , R 2 , and R 3 is independently hydrogen or methyl. Each such substituent is advantageous because it is advantageous in controlling the electronic and stereoscopic environment around the center metal (M) and can exhibit higher activity.
한편, 일 구현 예에 따른 올레핀 중합용 촉매는 상기 화학식 1로 표시되는 전이금속 화합물과 함께 조촉매 화합물을 포함할 수 있다.Meanwhile, the catalyst for olefin polymerization according to one embodiment may include a cocatalyst compound together with the transition metal compound represented by the formula (1).
상기 조촉매 화합물은 상기 화학식 1로 표시되는 전이금속 화합물을 활성화시킬 수 있는 통상의 화합물일 수 있으며; 바람직하게는 하기 화학식 3, 화학식 4 및 화학식 5로 표시되는 군에서 선택된 1종 이상의 화합물일 수 있다:The promoter compound may be a conventional compound capable of activating the transition metal compound represented by
[화학식 3](3)
-[Al(R31)-O]a-- [Al (R 31 ) -O] a -
상기 화학식 3에서,In Formula 3,
R31은 각각 독립적으로 수소, 할로겐 라디칼, 탄소수 1 내지 20의 하이드로카르빌 라디칼 또는 할로겐으로 치환된 탄소수 1 내지 20의 하이드로카르빌 라디칼이며; R 31 is each independently a hydrogen, a halogen radical, a hydrocarbyl radical having 1 to 20 carbon atoms or a hydrocarbyl radical having 1 to 20 carbon atoms substituted with halogen;
a는 2 이상의 정수이다;a is an integer of 2 or more;
[화학식 4][Chemical Formula 4]
D(R41)3 D (R < 41 > ) 3
상기 화학식 4에서, In Formula 4,
D는 알루미늄 또는 보론이며; D is aluminum or boron;
R41은 각각 독립적으로 할로겐 라디칼, 탄소수 1 내지 20의 하이드로카르빌 라디칼 또는 할로겐으로 치환된 탄소수 1 내지 20의 하이드로카르빌 라디칼이다.R 41 is each independently a halogen radical, a hydrocarbyl radical having 1 to 20 carbon atoms or a hydrocarbyl radical having 1 to 20 carbon atoms substituted with halogen.
[화학식 5][Chemical Formula 5]
[L-H]+[Z(A)4]- 또는 [L]+[Z(A)4]- [LH] + [Z (A ) 4] - or [L] + [Z (A ) 4] -
상기 화학식 5에서,In
L은 중성 또는 양이온성 루이스 염기이고; L is a neutral or cationic Lewis base;
[L-H]+ 또는 [L]+ 는 브론스테드 산이고;[LH] + or [L] + is a Bronsted acid;
H는 수소 원자이고;H is a hydrogen atom;
Z는 13족 원소이고; Z is a
A는 각각 독립적으로 1 이상의 수소 원자가 할로겐, 탄소수 1 내지 20의 하이드로카르빌, 탄소수 1 내지 20의 알콕시 또는 탄소수 6 내지 20의 아릴옥시 라디칼로 치환된 탄소수 6 내지 20의 아릴 또는 탄소수 1 내지 20의 알킬 라디칼이다.A is independently selected from the group consisting of a hydrogen atom, a halogen atom, a hydrocarbyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryloxy group having 6 to 20 carbon atoms, an aryl group having 6 to 20 carbon atoms, Alkyl radical.
이때, 상기 조촉매 화합물이 보다 우수한 활성화 효과를 나타낼 수 있도록 하기 위하여, 상기 화학식 3의 R31은 메틸, 에틸, n-부틸 또는 이소부틸이고; 상기 화학식 4의 D는 알루미늄, R41은 메틸 또는 이소부틸이고; 또는 D는 보론, R41은 펜타플루오로페닐이며; 상기 화학식 5에서 [L-H]+는 디메틸아닐리늄 양이온이고; [Z(A)4]-는 [B(C6F5)4]-이고; [L]+는 [(C6H5)3C]+인 것이 바람직하다.Here, in order that the above-mentioned co-catalyst compound can exhibit a better activation effect, R 31 in the above formula (3) is methyl, ethyl, n-butyl or isobutyl; D in the formula 4 is aluminum, R 41 is methyl or isobutyl; Or D is boron and R < 41 > is pentafluorophenyl; [LH] + in the above formula (5) is a dimethylanilinium cation; [Z (A) 4 ] - is [B (C 6 F 5 ) 4 ] - ; [L] + is preferably [(C 6 H 5 ) 3 C] + .
그리고, 상기 조촉매 화합물의 함량은, 상기 화학식 1로 표시되는 전이금속 화합물에 함유된 전이금속 1몰에 대하여, 조촉매 화합물에 함유된 금속의 몰비를 기준으로 1:1 내지 1:100,000, 바람직하게는 1:1 내지 1:10,000, 보다 바람직하게는 1:1 내지 1:1,000일 수 있다.The content of the co-catalyst compound is preferably from 1: 1 to 1: 100,000, more preferably from 1: 1 to 1: 100,000 based on the molar ratio of the metal contained in the co-catalyst compound to one mole of the transition metal contained in the transition metal compound represented by the formula 1: 1 to 1: 10,000, more preferably 1: 1 to 1: 1,000.
한편, 일 구현 예에 따른 올레핀 중합용 촉매는, 상기 화학식 1로 표시되는 화합물이 담지되는 불활성 담체를 포함할 수 있다. 상기 담체로는 본 발명이 속하는 기술분야에서 통상적인 무기 또는 유기 소재의 담체가 제한 없이 사용될 수 있으며; 바람직하게는 SiO2, Al2O3 , MgO, MgCl2, CaCl2, ZrO2, TiO2, B2O3, CaO, ZnO, BaO, ThO2, SiO2-Al2O3, SiO2-MgO, SiO2-TiO2, SiO2-V2O5, SiO2-CrO2O3, SiO2-TiO2-MgO, 보오크사이트, 제올라이트 등일 수 있다.
Meanwhile, the catalyst for olefin polymerization according to one embodiment may include an inert carrier on which the compound represented by
한편, 본 발명의 다른 구현 예에 따르면, 전술한 촉매의 존재 하에서, 적어도 1 종의 올레핀계 단량체를 중합시키는 단계를 포함하는 폴리올레핀의 제조 방법이 제공된다.According to another embodiment of the present invention, there is provided a process for producing a polyolefin comprising polymerizing at least one olefin-based monomer in the presence of the above-mentioned catalyst.
이때, 상기 올레핀계 단량체는 탄소수 2 내지 20의 알파-올레핀(α-olefin), 탄소수 1 내지 20의 디올레핀(diolefin), 탄소수 3 내지 20의 사이클로올레핀(cyclo-olefin) 또는 탄소수 3 내지 20의 사이클로디올레핀(cyclo-diolefin), 치환 또는 비치환된 스티렌으로 이루어진 군에서 선택되는 1종 이상일 수 있다.The olefin-based monomer may be an α-olefin having 2 to 20 carbon atoms, a diolefin having 1 to 20 carbon atoms, a cyclo-olefin having 3 to 20 carbon atoms, or a cycloolefin having 3 to 20 carbon atoms Cyclo-olefin, substituted or unsubstituted styrene, and the like.
바람직하게는, 상기 올레핀계 단량체는 에틸렌(ethylene), 프로필렌(propylene), 1-부텐(1-butene), 1-펜텐(1-pentene) 및 1-헥센(1-hexene)을 포함하는 탄소수 2 내지 20의 알파-올레핀(α-olefin); 1,3-부타디엔(1,3-butadiene), 1,4-펜타디엔(1,4-pentadiene) 및 2-메틸-1,3-부타디엔(2-methyl-1,3-butadiene)을 포함하는 탄소수 1 내지 20의 디올레핀(diolefin); 사이클로펜텐(cyclopentene), 사이클로헥센(cyclohexene), 사이클로펜타디엔(cyclopentadiene), 사이클로헥사디엔(cyclohexadiene), 노르보넨(norbonene) 및 메틸-2-노르보넨(methyl-2-norbonene)을 포함하는 탄소수 3 내지 20의 사이클로올레핀(cyclo-olefin) 또는 사이클로디올레핀(cyclo-diolefin); 스티렌(styrene) 또는 스티렌의 페닐 고리(phenyl ring)에 탄소수 1 내지 10의 알킬기, 알콕시기, 할로겐기, 아민기, 실릴기, 할로알킬기 등이 결합된 치환된 스티렌(substituted styrene); 또는 이들의 혼합물일 수 있다.Preferably, the olefinic monomer has a number of carbon atoms of 2 or more, including ethylene, propylene, 1-butene, 1-pentene and 1-hexene. To 20 alpha-olefins; But are not limited to those containing 1,3-butadiene, 1,4-pentadiene and 2-methyl-1,3-butadiene. A diolefin having 1 to 20 carbon atoms; The number of carbons including 3 carbon atoms, including cyclopentene, cyclohexene, cyclopentadiene, cyclohexadiene, norbonene and methyl-2-norbonene, Cyclo-olefin or cyclo-diolefin of from 1 to 20 carbon atoms; Substituted styrene in which an alkyl group, an alkoxy group, a halogen group, an amine group, a silyl group, a haloalkyl group or the like is bonded to a phenyl ring of styrene or styrene; Or a mixture thereof.
또한, 상기 올레핀계 단량체를 중합시키는 단계는 슬러리상(slurry phase), 액상(solution phase), 기상(gas phase) 또는 괴상(bulk phase)에서 실시될 수 있다.The step of polymerizing the olefin-based monomer may be carried out in a slurry phase, a solution phase, a gas phase, or a bulk phase.
상기 중합 단계가 액상 또는 슬러리상에서 실시될 경우에는 용매 또는 올레핀계 단량체 자체를 매질로 사용할 수 있다.When the polymerization step is carried out in a liquid phase or a slurry, the solvent or the olefin-based monomer itself can be used as a medium.
또한, 상기 중합 단계에 사용 가능한 용매는 부탄(butane), 이소부탄(isobutane), 펜탄(pentane), 헥산(hexane), 헵탄(heptane), 옥탄(octane), 노난(nonane), 데칸(decane), 운데칸(undecane), 도데칸(dodecane), 시클로펜탄(cyclopentane), 메틸시클로펜탄(methylcyclopentane), 시클로헥산(cyclohexane) 등의 지방족 탄화수소계 용매; 벤젠(benzene), 모노클로로벤젠(monochlorobenzene), 디클로로벤젠(dichlorobenzene), 트리클로로벤젠(trichlorobenzene), 톨루엔(toluene), 자일렌(xylene), 클로로벤젠(chlorobenzene) 등의 방향족 탄화수소계 용매; 디클로로메탄(dichloromethane), 트리클로로메탄(trichloromethane), 클로로에탄(chloroethane), 디클로로에탄(dichloroethane), 트리클로로에탄(trichloroethane), 1,2-디클로로에탄(1,2-dichloroethane) 등의 할로겐화 지방족 탄화수소 용매; 또는 이들의 혼합물일 수 있다.The solvent used in the polymerization step may be selected from the group consisting of butane, isobutane, pentane, hexane, heptane, octane, nonane, decane, Aliphatic hydrocarbon solvents such as undecane, dodecane, cyclopentane, methylcyclopentane, cyclohexane and the like; Aromatic hydrocarbon solvents such as benzene, monochlorobenzene, dichlorobenzene, trichlorobenzene, toluene, xylene, chlorobenzene and the like; Halogenated aliphatic hydrocarbons such as dichloromethane, trichloromethane, chloroethane, dichloroethane, trichloroethane, and 1,2-dichloroethane, menstruum; Or a mixture thereof.
또한, 상기 중합 단계는 배치식(batch type), 반연속식(semi-continuous type) 또는 연속식(continuous type) 반응으로 수행할 수 있다. 그리고, 상기 중합 단계의 온도 및 압력 조건은 적용하고자 하는 반응의 종류 및 반응기의 종류에 따라 중합 반응의 효율을 고려하여 결정될 수 있다.The polymerization may be carried out in a batch type, semi-continuous type or continuous type reaction. The temperature and pressure conditions of the polymerization step may be determined in consideration of the efficiency of the polymerization reaction depending on the kind of the reaction to be applied and the kind of the reactor.
한편, 상기 방법을 통해 제조되는 폴리올레핀은 2 내지 30, 또는 2.5 내지 25, 또는 2.5 내지 22의 분자량 분포(Mw/Mn)를 가질 수 있다. 그리고, 상기 방법을 통해 제조되는 폴리올레핀은 40,000 이상, 또는 40,000 내지 1,000,000, 또는 45,000 내지 800,000의 중량평균분자량(Mw)를 가질 수 있다.
On the other hand, the polyolefin prepared by the above method may have a molecular weight distribution (Mw / Mn) of 2 to 30, or 2.5 to 25, or 2.5 to 22. The polyolefin prepared by the above method may have a weight average molecular weight (Mw) of 40,000 or more, or 40,000 to 1,000,000, or 45,000 to 800,000.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예들을 제시한다. 그러나 하기의 실시예들은 본 발명을 예시하기 위한 것일 뿐, 본 발명의 범위를 이들만으로 한정하는 것은 아니다.Best Mode for Carrying Out the Invention Hereinafter, preferred embodiments are described to facilitate understanding of the present invention. However, the following examples are intended to illustrate the present invention, but the scope of the present invention is not limited thereto.
비교예Comparative Example 1 One
도 1에 나타낸 Scheme에 따라 하기 화합물 3을 합성하였다. 이하, 각 화합물의 합성에 대하여 설명한다.The following
[화합물 3][Compound 3]
(1) 화합물 1의 합성(1) Synthesis of
: 250 mL Schlenk 플라스크에 1,2,3,4-tetramethyl-1,3-cyclopentadiene (30 mmol, 3.67 g)를 넣어준 후 tetrahydropyran (THF) 30 mL로 녹인 후에 드라이아이스/아세톤을 이용하여 -78 ℃로 낮춰주었다. 1.1 당량의 n-BuLi (33 mmol, 13.2 mL)를 주사기로 천천히 가해준 후 서서히 상온으로 승온시켜 2시간동안 교반하였다. 리튬 음이온 용액을 -78 ℃로 낮춘 후 2.5 당량의 Me2SiCl2 (75 mmol, 9 mL)를 주사기를 이용하여 천천히 가한 후에 서서히 상온으로 올려 15시간 동안 교반하였다. 진공 하에서 모든 용매를 제거한 뒤 n-Hexane으로 추출한다. 혼합물을 Celite bed로 salt를 제거한 후에 진공 하에서 모든 용매를 제거하여 77.9 % (5.02 g)의 수율로 노란색 오일의 화합물 1을 얻었다. : To a 250 mL Schlenk flask, 1,2,3,4-tetramethyl-1,3-cyclopentadiene (30 mmol, 3.67 g) was added and dissolved in 30 mL of tetrahydropyran (THF) Lt; / RTI > 1.1 equivalents of n-BuLi (33 mmol, 13.2 mL) was added slowly by syringe, then slowly warmed to room temperature and stirred for 2 hours. After the lithium anion solution was lowered to -78 ° C, 2.5 equivalents of Me 2 SiCl 2 (75 mmol, 9 mL) was slowly added thereto by using a syringe, then slowly raised to room temperature and stirred for 15 hours. Remove all solvents under vacuum and extract with n-hexane. After removing the salt from the mixture with a Celite bed, all the solvent was removed under vacuum to obtain
(2) 화합물 2의 합성(2) Synthesis of
: 250 mL Schlenk 플라스크에 화합물 1 (23.3 mmol, 5 g)을 넣어준 후 THF 30 mL로 녹인 후에 드라이아이스/아세톤을 이용하여 -78 ℃로 낮춰주었다. 여기에 3당량의 t-BuNH2를 주사기를 이용하여 천천히 가해준 뒤 서서히 상온으로 승온시켜 15시간동안 교반하였다. 진공 하에서 모든 용매를 제거한 뒤 n-Hexane으로 추출한다. 혼합물을 Celite bed로 salt를 제거한 후에 진공 하에서 모든 용매를 제거하여 86.1 % (5.05 g)의 수율로 끈적한 옅은 노란색 오일의 화합물 2를 얻었다. : Compound 1 (23.3 mmol, 5 g) was added to a 250 mL Schlenk flask and dissolved in 30 mL of THF, and then the temperature was lowered to -78 ° C using dry ice / acetone. Three equivalents of t-BuNH 2 were slowly added thereto by using a syringe, and then the temperature was gradually raised to room temperature and stirred for 15 hours. Remove all solvents under vacuum and extract with n-hexane. After removing the salt from the mixture with a Celite bed, all the solvent was removed under vacuum to obtain
(3) 화합물 3의 합성(3) Synthesis of
: 250 mL Schlenk 플라스크에 화합물 2 (7.95 mmol, 2 g)를 넣어준 후 THF 30 mL로 녹여준 뒤 드라이아이스/아세톤을 이용하여 -78 ℃로 낮춰주었다. 2.1당량의 n-BuLi(16.7 mmol, 6.7 mL)를 주사기로 천천히 가해준 후 서서히 상온으로 승온시켜 2시간동안 교반하였다. 2시간 후에 미리 -78 ℃로 낮춘 0.98당량의 TiCl3(THF)3(7.79 mmol, 2.88 g)의 THF 슬러리로 리튬 음이온 용액을 캐뉼라를 이용하여 빠르게 가한다. 반응물을 서서히 상온으로 승온시켜 15시간동안 교반하였다. 혼합 용액을 1.1 당량의 AgCl이 담긴 250 mL Schlenk 플라스크로 빠르게 적가하여 1시간동안 더 교반해 주었다. 진공 하에서 모든 용매를 제거한 뒤 n-Hexane으로 추출하였다. 혼합물을 Celite bed로 salt를 제거한 후에 진공 하에서 모든 용매를 제거하여 56.4 % (1.65 g)의 수율로 황갈색의 고체 화합물 3을 얻었다.: Compound 2 (7.95 mmol, 2 g) was added to a 250 mL Schlenk flask, dissolved with 30 mL of THF, and then cooled down to -78 ° C using dry ice / acetone. 2.1 equivalents of n-BuLi (16.7 mmol, 6.7 mL) was added slowly by syringe, then slowly warmed to room temperature and stirred for 2 hours. After 2 hours, the lithium anion solution was rapidly added to the THF slurry of 0.98 equivalents of TiCl 3 (THF) 3 (7.79 mmol, 2.88 g) previously lowered to -78 ° C using a cannula. The reaction was slowly warmed to room temperature and stirred for 15 hours. The mixed solution was rapidly added dropwise to a 250 mL Schlenk flask containing 1.1 equivalents of AgCl and further stirred for 1 hour. All solvents were removed under vacuum and extracted with n-hexane. After removing the salt from the mixture with a Celite bed, all the solvent was removed under vacuum to obtain a yellowish brown
화합물 3의 NMR 스펙트럼을 아래에 나타내었다 (도 2 참조).NMR spectrum of
1H NMR (CDCl3, 400.13 MHz): δ 2.22 (s, 6H, Cp(CH3)2), 2.12 (s, 6H, Cp(CH3)2), 1.42(s, 9H, N(CH3)3), 0.69(s, 6H, Si(CH3)3).
1 H NMR (CDCl 3, 400.13 MHz): δ 2.22 (s, 6H, Cp (CH 3) 2), 2.12 (s, 6H, Cp (CH 3) 2), 1.42 (s, 9H, N (
비교예Comparative Example 2 2
하기 화학식으로 표시되는 Ind2HfCl2를 비교예 2로 준비하였다.Ind 2 HfCl 2 represented by the following formula was prepared as Comparative Example 2.
[Ind2HfCl2][Ind 2 HfCl 2 ]
실시예Example 1 One
도 3에 나타낸 Scheme에 따라 하기 화합물 7을 합성하였다. 이하, 각 화합물의 합성에 대하여 설명한다.The following
[화합물 7][Compound 7]
(1) 화합물 4의 합성(1) Synthesis of Compound 4
: 250mL Schlenk 플라스크에 2,3,4-Trimethylcyclopent-2-enone (16.5 mmol, 2.05 g)을 넣고 THF 20 mL에 녹였다. 다른 250 mL Schlenk 플라스크에 4-(N,N-dimethyl)aniline magnesium bromide 0.5M 용액(15 mmol, 30 mL)을 주사기를 이용하여 가한 후에 THF 30mL에 녹였다. 4-(N,N-dimethyl)aniline magnesium bromide 용액의 드라이아이스/아세톤을 이용하여 -78 ℃로 낮추었다. 2,3,4-Trimethylcyclopent-2-enone 용액을 4-(N,N-dimethyl)aniline magnesium bromide 용액으로 천천히 가하였다. 서서히 상온으로 승온시켜 15시간동안 교반한 후, 포화 NH4Cl 수용액 60 mL를 천천히 가하여 반응을 종결시킨 후에 diethyl ether로 3회 추출하였다. 얻어진 유기층을 MgSO4로 수분을 모두 제거하고 진공 하에서 모든 용매를 제거하였다. 추출물을 dichloromethane 15 mL에 녹인 후에 상온에서 p-톨루엔술폰산 (p-TsOH)을 소량 첨가하여 1시간동안 교반하였다. 반응 종결 후에 diethyl ether로 3회 추출하였다. 얻어진 유기층을 MgSO4로 수분을 모두 제거하고 진공 하에서 모든 용매를 제거하였다. 생성물을 최소한의 에탄올로 재결정하였으며, 얻어진 생성물을 필터하고 소량의 차가운 n-Hexane으로 불순물을 제거하여 77.7 % (2.65 g)의 수율로 옅은 핑크색의 고체 화합물 4을 얻을 수 있었다. : 2,3,4-Trimethylcyclopent-2-enone (16.5 mmol, 2.05 g) was added to a 250 mL Schlenk flask and dissolved in 20 mL of THF. A 0.5 M solution of 4- (N, N-dimethyl) aniline magnesium bromide (15 mmol, 30 mL) was added to another 250 mL Schlenk flask using a syringe and dissolved in 30 mL of THF. Was lowered to -78 ° C using dry ice / acetone of 4- (N, N-dimethyl) aniline magnesium bromide solution. The 2,3,4-Trimethylcyclopent-2-enone solution was slowly added to the 4- (N, N-dimethyl) aniline magnesium bromide solution. After slowly raising the temperature to room temperature and stirring for 15 hours, 60 mL of a saturated aqueous NH 4 Cl solution was added slowly to terminate the reaction, followed by extraction with diethyl ether three times. The obtained organic layer was washed with MgSO 4 to remove all of the water and all the solvent was removed under vacuum. After dissolving the extract in 15 mL of dichloromethane, a small amount of p-toluenesulfonic acid (p-TsOH) was added at room temperature and stirred for 1 hour. After completion of the reaction, the mixture was extracted three times with diethyl ether. The obtained organic layer was washed with MgSO 4 to remove all of the water and all the solvent was removed under vacuum. The product was recrystallized with a minimum of ethanol. The obtained product was filtered and impurities were removed with a small amount of cold n-hexane to obtain a pale pink solid compound 4 in a yield of 77.7% (2.65 g).
화합물 4의 NMR 스펙트럼을 아래에 나타내었다 (도 4 및 도 5 참조).The NMR spectrum of Compound 4 is shown below (see Figs. 4 and 5).
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.25 (d, 2H, J = 8.84 Hz, Ph), 6.75 (d, 2H, J = 8.88 Hz, Ph), 3.15 (t, 2H, J = 8.42 Hz, Cp(H2)), 2.95 (s, 6H, N(CH3)2), 2.06 (t, 3H, J = 2.1 Hz, Cp(CH3)3), 1.98 (s, 3H, Cp(CH3)3), 1.86 (d, 3H, J = 1.04 Hz, Cp(CH3)3). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.25 (d, 2H, J = 8.84 Hz, Ph), 6.75 (d, 2H, J = 8.88 Hz, Ph), 3.15 (t, 2H, J = 8.42 Hz, Cp (H 2) ), 2.95 (s, 6H, N (CH 3) 2), 2.06 (t, 3H, J = 2.1 Hz, Cp (CH 3) 3), 1.98 (s, 3H, Cp (CH 3) 3), 1.86 (d, 3H, J = 1.04 Hz, Cp (CH 3) 3).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 148.34, 137.26, 136.54, 135.85, 133.67, 128.23, 126.96, 112.72 (Ph, Cp), 46.74 (N(CH3)2), 40.78 (Cp), 13.49, 13.01, 11.23 (Cp(CH3)3). 13 C {1 H} NMR (
(2) 화합물 5의 합성(2) Synthesis of
: 화합물 5는 화합물 1의 합성 경로와 같은 방법을 적용하였다. 화합물 4 (5.7 mmol, 1.3 g), 1.1당량의 n-BuLi(6.3 mmol, 2.5 mL) 및 2.5 당량의 Me2SiCl2(14.3 mmol, 1.7 mL) 사용하여 89.4 % (1.16 g)의 수율로 무색의 고체 화합물 5를 얻었다. :
화합물 5의 NMR 스펙트럼을 아래에 나타내었다 (도 6 참조).NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.08 (d, 2H, J = 7.44 Hz, Ph), 6.69 (d, 2H, J = 8.4 Hz, Ph), 3.69 (s, 1H, CpH2), 2.94 (s, 6H, N(CH3)2), 2.10 (s, 3H, Cp(CH3)3), 2.00 (d, 3H, J = 1.64 Hz, Cp(CH3)3), 1.88 (t, 3H, J = 1.1 Hz, Cp(CH3)3), 0.11 (s, 6H, Si(CH3)2). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.08 (d, 2H, J = 7.44 Hz, Ph), 6.69 (d, 2H, J = 8.4 Hz, Ph), 3.69 (s, 1H, CpH 2 ), 2.94 (s, 6H, N (CH 3) 2), 2.10 (s, 3H, Cp (CH 3) 3), 2.00 (d, 3H, J = 1.64 Hz, Cp (CH 3) 3), 1.88 (t, 3H, J = 1.1 Hz, Cp (CH 3) 3), 0.11 (s, 6H, Si (CH 3) 2).
(3) 화합물 6의 합성(3) Synthesis of
: 화합물 6은 화합물 2의 합성 경로와 같은 방법을 적용하였다. 화합물 5 (3.44 mmol, 1.1 g), 3당량의 t-BuNH2 (10.3 mmol, 1.1 mL)을 사용하여 99.6 % (1.22 g)의 수율로 끈적한 옅은 갈색의 오일 화합물 6를 얻었다. :
화합물 6의 NMR 스펙트럼을 아래에 나타내었다 (도 7 및 도 8 참조).NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.11 (m, 2H, Ph), 6.73 (m, 2H, Ph), 3.49 (s, 1H, Cp(H)), 2.93 (s, 6H, N(CH3)2), 2.06 (s, 3H, Cp(CH3)3), 1.99 (d, 3H, J = 1.52 Hz, Cp(CH3)3), 1.87 (s, 3H, Cp(CH3)3), 0.96 (s, 9H, NC(CH3)3), 0.16 (s, 3H, Si(CH3)2), -0.31 (s, 3H, Si(CH3)2). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.11 (m, 2H, Ph), 6.73 (m, 2H, Ph), 3.49 (s, 1H, Cp (H)), 2.93 (s, 6H, N (CH 3) 2), 2.06 (s, 3H, Cp (CH 3) 3), 1.99 (d, 3H, J = 1.52 Hz, Cp (CH 3) 3), 1.87 (s, 3H, Cp (CH 3) 3), 0.96 (s , 9H, NC (CH 3) 3), 0.16 (s, 3H, Si (CH 3) 2), -0.31 (s, 3H, Si (CH 3) 2).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 148.96, 138.28, 135.98, 135.36, 135.22, 130.07, 128.03, 112.66, 49.29 (Ph, Cp), 55.46 (NC), 40.94 (N(CH3)2), 33.67 (NC(CH3)3), 15.11, 12.64, 11.34 (Cp(CH3)3), 0.49, 0.30 (Si(CH3)2). 13 C {1 H} NMR (
(4) 화합물 7의 합성(4) Synthesis of
: 화합물 7은 화합물 3의 합성 경로와 같은 방법을 적용하였다. 화합물 6 (3.08 mmol, 1.1 g), 2.1 당량의 n-BuLi (3.4 mmol, 1.4 mL), 0.98 당량의 TiCl3(THF)3 (3.02 mmol, 1.12 g) 및 1.1 당량의 AgCl (3.39 mmol, 0.486 g)을 사용하여 71.4 % (0.962 g)의 수율로 붉은 갈색의 고체 화합물 7을 얻었다.:
화합물 7의 NMR 스펙트럼을 아래에 나타내었다 (도 9 및 도 10 참조). NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.10 (m, 2H, Ph), 6.73 (m, 2H, Ph), 2.93 (s, 6H, N(CH3)2), 2.05 (s, 3H, Cp(CH3)3), 1.99 (d, 3H, J = 1.48 Hz, Cp(CH3)3), 1.87 (s, 3H, Cp(CH3)3), 0.95 (s, 9H, NC(CH3)3), 0.16 (s, 3H, Si(CH3)2), -0.31 (s, 3H, Si(CH3)2). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.10 (m, 2H, Ph), 6.73 (m, 2H, Ph), 2.93 (s, 6H, N (CH 3) 2), 2.05 (s, 3H, Cp (CH 3) 3 ), 1.99 (d, 3H, J = 1.48 Hz, Cp (CH 3) 3), 1.87 (s, 3H, Cp (CH 3) 3), 0.95 (s, 9H, NC (CH 3) 3), 0.16 (s, 3H, Si (CH 3) 2), -0.31 (s, 3H, Si (CH 3) 2).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 148.78, 138.12, 135.22, 135.08, 129.92, 127.88, 112.51 (Ph, Cp), 55.33 (NC), 40.78 (N(CH3)2), 33.52 (NC(CH3)3), 11.18, 12.45, 14.95 (Cp(CH3)3), 0.14, 0.34 (Si(CH3)2).
13 C {1 H} NMR (
실시예Example 2 2
도 11에 나타낸 Scheme에 따라 하기 화합물 11을 합성하였다. 이하, 각 화합물의 합성에 대하여 설명한다.The following
[화합물 11][Compound 11]
(1) 화합물 8의 합성(1) Synthesis of
: 화합물 8은 화합물 4의 합성 경로와 같은 방법을 적용하였다. 2,3,4-Trimethylcyclopent-2-enone (16.5 mmol, 2.05 g), 4-methoxyphenyl magnesium bromide 용액 (15 mmol, 30 mL)을 사용하여 83.7 % (3.2 g)의 수율로 흰색의 고체 화합물 8을 얻었다. :
화합물 8의 NMR 스펙트럼을 아래에 나타내었다 (도 12 및 도 13 참조).NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.23 (m, 2H, PhH2), 6.86 (m, 2H, PhH2), 3.80(s, 3H, PhOCH3), 3.13(t, 2H, J = 1.80 Hz, CpH2), 2.02 (t, 3H, J = 1.72 Hz, Cp(CH3)), 1.96 (s, 3H, Cp(CH3)), 1.84 (d, 3H, J = 1.00 Hz, Cp(CH3)). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.23 (m, 2H, PhH 2), 6.86 (m, 2H, PhH 2), 3.80 (s, 3H, PhOCH 3), 3.13 (t, 2H, J = 1.80 Hz, CpH 2) , 2.02 (t, 3H, J = 1.72 Hz, Cp (CH 3)), 1.96 (s, 3H, Cp (CH 3)), 1.84 (d, 3H, J = 1.00 Hz , Cp (CH 3)).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 157.50, 137.67, 137.23, 135.42, 134.33, 130.92, 128.52, 113.70 (Ph, Cp), 55.26 (PhOCH3), 46.90 (Cp), 13.50, 12.98, 11.23 (Cp(CH3)3). 13 C {1 H} NMR (
(2) 화합물 9의 합성(2) Synthesis of Compound 9
: 화합물 9는 화합물 1의 합성 경로와 같은 방법을 적용하였다. 화합물 8 (4.66 mmol, 1.0 g), 1.1당량의 n-BuLi (5.1 mmol, 2.1 mL) 및 2.5 당량의 Me2SiCl2 (11.6 mmol, 1.4 mL) 사용하여 93.7 % (1.34 g)의 수율로 밝은 갈색의 오일 화합물 9를 얻었다. : Compound 9 was applied in the same manner as the synthesis route of
화합물 9의 NMR 스펙트럼을 아래에 나타내었다 (도 14 참조).NMR spectrum of Compound 9 is shown below (see Fig. 14).
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.11 (m, 2H, Ph), 6.85 (m, 2H, Ph), 3.80(s, 3H, PhOCH3), 3.69 (s, 1H, CpH), 2.11 (s, 3H, Cp(CH3)), 2.18 (d, 3H, J = 1.60 Hz, Cp(CH3)), 1.89 (s, 3H, Cp(CH3)), 0.10 (s, 3H, Si(CH3)), 0.13 (s, 3H, Si(CH3)). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.11 (m, 2H, Ph), 6.85 (m, 2H, Ph), 3.80 (s, 3H, PhOCH 3), 3.69 (s, 1H, CpH) , 2.11 (s, 3H, Cp (CH 3)), 2.18 (d, 3H, J = 1.60 Hz, Cp (CH 3)), 1.89 (s, 3H, Cp (CH 3)), 0.10 (s, 3H , Si (CH 3)), 0.13 (s, 3H, Si (CH 3)).
(3) 화합물 10의 합성(3) Synthesis of
: 화합물 10은 화합물 2의 합성 경로와 같은 방법을 적용하였다. 화합물 9 (4.33 mmol, 1.33 g), 3당량의 t-BuNH2(13.0 mmol, 1.4 mL)을 사용하여 92.0 % (1.37 g)의 수율로 끈적한 옅은 노란색의 오일 화합물 10을 얻었다. :
화합물 10의 NMR 스펙트럼을 아래에 나타내었다 (도 15 및 도 16 참조).NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.10 (m, 2H, Ph), 6.85 (m, 2H, Ph), 3.80(s, 3H, PhOCH3), 3.49 (s, 1H, CpH), 2.05 (s, 3H, Cp(CH3)), 1.97 (d, 3H, J = 1.56 Hz, Cp(CH3)), 1.89 (s, 3H, Cp(CH3)), 0.95(s, 9H, NC(CH3)3), 0.21 (s, 3H, Si(CH3)), 0.33 (s, 3H, Si(CH3)). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.10 (m, 2H, Ph), 6.85 (m, 2H, Ph), 3.80 (s, 3H, PhOCH 3), 3.49 (s, 1H, CpH) , 2.05 (s, 3H, Cp (CH 3)), 1.97 (d, 3H, J = 1.56 Hz, Cp (CH 3)), 1.89 (s, 3H, Cp (CH 3)), 0.95 (s, 9H , NC (CH 3) 3) , 0.21 (s, 3H, Si (CH 3)), 0.33 (s, 3H, Si (CH 3)).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 157.68, 137.54, 136.08, 135.88, 135.79, 131.88, 130.21, 113.48 (Ph, Cp), 55.56 (NC), 55.28 (PhOCH3), 49.18 (Cp), 33.53(NC(CH3)3), 14.97, 12.46, 11.17 (Cp(CH3)3), 0.59, 0.01 (Si(CH3)2). 13 C {1 H} NMR (
(4) 화합물 11의 합성(4) Synthesis of
: 화합물 11은 화합물 3의 합성 경로와 같은 방법을 적용하였다. 화합물 10 (3.78 mmol, 1.3 g), 2.1 당량의 n-BuLi (7.94 mmol, 3.2 mL), 0.98 당량의 TiCl3(thf)3 (3.7 mmol, 1.37 g) 및 1.1 당량의 AgCl (4.16 mmol, 0.596 g)을 사용하여 68.4 % (1.05 g)의 수율로 짙은 붉은색의 고체 화합물 11을 얻었다. :
화합물 11의 NMR 스펙트럼을 아래에 나타내었다 (도 17 및 도 18 참조).NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 6.81 (m, 4H, Ph), 3.80(s, 3H, PhOCH3), 2.26 (s, 3H, Cp(CH3)), 2.20 (s, 3H, Cp(CH3)), 2.13 (s, 3H, Cp(CH3)), 1.35(s, 9H, NC(CH3)3), 0.60 (s, 3H, Si(CH3)), 0.16 (s, 3H, Si(CH3)). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 6.81 (m, 4H, Ph), 3.80 (s, 3H, PhOCH 3), 2.26 (s, 3H, Cp (CH 3)), 2.20 (s, 3H, Cp (CH 3)) , 2.13 (s, 3H, Cp (CH 3)), 1.35 (s, 9H, NC (CH 3) 3), 0.60 (s, 3H, Si (CH 3)), 0.16 (s, 3H, Si (CH 3)).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 159.46, 147.97, 142.10, 137.73, 137.07, 127.61, 113.03, 104.57 (Ph, Cp), 63.00 (NC), 55.19 (PhOCH3), 32.59(NC(CH3)3), 16.17, 13.30, 13.29 (Cp(CH3)3), 4.90, 4.07 (Si(CH3)2).
13 C {1 H} NMR (
실시예Example 3 3
도 19에 나타낸 Scheme에 따라 하기 화합물 15를 합성하였다. 이하, 각 화합물의 합성에 대하여 설명한다.The following
[화합물 15][Compound 15]
(1) 화합물 12의 합성 (1) Synthesis of
250 mL Schlenk 플라스크에 2,3,4-trimethylcyclopent-2-enone (6.18 mmol, 0.767 g)을 넣고 THF 20 mL에 녹였다. 다른 250 mL Schlenk 플라스크에 4-thioanisolemagnesium bromide 0.5 M 용액 (5.88 mmol, 11.8 mL)을 주사기를 이용하여 가한 후에 THF 30 mL에 녹였다. 4-thioanisolemagnesium bromide 용액의 드라이아이스/아세톤을 이용하여 -78℃로 낮추었다. 2,3,4-trimethylcyclopent-2-enone 용액을 4-thioanisolemagnesium bromide 용액으로 천천히 가하였다. 서서히 상온으로 승온시켜 15 시간 동안 교반한 후, 포화 NH4Cl 수용액 30 mL를 천천히 가하여 반응을 종결시킨 후에 diethyl ether로 3회 추출하였다. 얻어진 유기층을 MgSO4로 수분을 모두 제거하고 진공 하에서 모든 용매를 제거하였다. 추출물을 dichloromethane 15 mL에 녹인 후에 상온에서 p-톨루엔술폰산 (p-TsOH)을 소량 첨가하여 1 시간 동안 교반하였다. 반응 종결 후에 diethyl ether로 3회 추출하였다. 얻어진 유기층을 MgSO4로 수분을 모두 제거하고 진공 하에서 모든 용매를 제거하였다. 생성물을 소량의 차가운 메탄올로 불순물을 제거하여 92.9 % (1.26 g)의 수율로 옅은 상아색의 고체인 화합물 12를 얻을 수 있었다.2,3,4-trimethylcyclopent-2-enone (6.18 mmol, 0.767 g) was added to a 250 mL Schlenk flask and dissolved in 20 mL of THF. In another 250 mL Schlenk flask, a 0.5 M solution of 4-thioanisolemagnesium bromide (5.88 mmol, 11.8 mL) was added using a syringe and dissolved in THF (30 mL). 4-thioanisolemagnesium bromide solution to -78 < 0 > C using dry ice / acetone. The 2,3,4-trimethylcyclopent-2-enone solution was slowly added to the 4-thioanisolemagnesium bromide solution. After slowly raising the temperature to room temperature and stirring for 15 hours, 30 mL of a saturated aqueous NH 4 Cl solution was added slowly to terminate the reaction, followed by three extractions with diethyl ether. The obtained organic layer was washed with MgSO 4 to remove all of the water and all the solvent was removed under vacuum. After dissolving the extract in 15 mL of dichloromethane, a small amount of p-toluenesulfonic acid (p-TsOH) was added at room temperature and stirred for 1 hour. After completion of the reaction, the mixture was extracted three times with diethyl ether. The obtained organic layer was washed with MgSO 4 to remove all of the water and all the solvent was removed under vacuum. The product was washed with a small amount of cold methanol to remove impurities, and
화합물 12의 NMR 스펙트럼을 아래에 나타내었다 (도 20 및 도 21 참조).The NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.23 (q, 4H, J = 2.97 Hz, Ph), 3.14 (q, 2H, J = 1.72 Hz, Cp(H2)), 2.47 (s, 3H, SMe), 2.04 (t, 3H, J = 1.88 Hz, Cp(CH3)3), 1.97 (s, 3H, Cp(CH3)3), 1.84 (d, 3H, J = 1.12 Hz, Cp(CH3)3). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.23 (q, 4H, J = 2.97 Hz, Ph), 3.14 (q, 2H, J = 1.72 Hz, Cp (H 2)), 2.47 (s, 3H, SMe), 2.04 (t , 3H, J = 1.88 Hz, Cp (CH 3) 3), 1.97 (s, 3H, Cp (CH 3) 3), 1.84 (d, 3H, J = 1.12 Hz, Cp (CH 3) 3).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 139.11, 137.38, 135.21, 135.14, 135.12, 134.82, 127.82, 126.9 (Ph, Cp), 46.66 (Cp), 16.21 (SMe), 11.19, 13.14, 13.54 (Cp(CH3)3). 13 C {1 H} NMR (
(2) 화합물 13의 합성 (2) Synthesis of
250 mL Schlenk 플라스크에 화합물 12 (2.24 mmol, 0.517 g)를 넣어준 후 THF 30 mL로 녹인 후에 드라이아이스/아세톤을 이용하여 -78℃로 낮춰주었다. 1.1당량의 n?uLi (2.46 mmol, 1 mL)를 주사기로 천천히 가해준 후 서서히 상온으로 승온시켜 2 시간 동안 교반하였다. 리튬 음이온 용액을 -78℃로 낮춘 후 2.5 당량의 Me2SiCl2 (5.6 mmol, 0.68 mL)를 주사기를 이용하여 천천히 가한 후에 서서히 상온으로 올려 15 시간 동안 교반하였다. 진공 하에서 모든 용매를 제거한 뒤 n Hexane으로 추출한다. 혼합물을 Celite bed로 salt를 제거한 후에 진공 하에서 모든 용매를 제거하여 99.5 % (0.72 g)의 수율로 노란색의 고체인 화합물 13을 얻었다.Compound 12 (2.24 mmol, 0.517 g) was added to a 250 mL Schlenk flask, which was then dissolved in 30 mL of THF and then cooled to -78 ° C using dry ice / acetone. 1.1 eq. Of nuLi (2.46 mmol, 1 mL) was added slowly by syringe, then slowly warmed to room temperature and stirred for 2 hours. After the lithium anion solution was cooled to -78 ° C, 2.5 equivalents of Me 2 SiCl 2 (5.6 mmol, 0.68 mL) was slowly added thereto by using a syringe, then slowly raised to room temperature and stirred for 15 hours. Remove all solvents under vacuum and extract with n-hexane. After removing the salt from the mixture with a Celite bed, all the solvent was removed under vacuum to obtain a yellow
화합물 13의 NMR 스펙트럼을 아래에 나타내었다 (도 22 및 도 23 참조).NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.21 (m, 2H, Ph), 7.12 (m, 2H, Ph), 3.73 (s, 1H, Cp(H)), 2.48 (s, 3H, SMe), 2.12 (s, 3H, Cp(CH3)3), 2.02 (d, 3H, J = 1.68 Hz, Cp(CH3)3), 1.9 (s, 3H, Cp(CH3)3), -0.085, (s, 3H, Si(CH3)2), -0.094 (s, 3H, Si(CH3)2)). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.21 (m, 2H, Ph), 7.12 (m, 2H, Ph), 3.73 (s, 1H, Cp (H)), 2.48 (s, 3H, SMe), 2.12 (s, 3H , Cp (CH 3) 3), 2.02 (d, 3H, J = 1.68 Hz, Cp (CH 3) 3), 1.9 (s, 3H, Cp (CH 3) 3), -0.085, (s, 3H, Si (CH 3) 2), -0.094 (s, 3H, Si (CH 3) 2)).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 139.6, 137.89, 136.09, 135.89, 134.68, 134.52, 129.38, 126.48 (Ph, Cp), 54.84 (Cp), 15.97 (Cp(CH3)3), 14.71 (SMe), 11.21, 12.77 (Cp(CH3)3), 2.87 (Si(CH3)2), -2.33 (Si(CH3)2). 13 C {1 H} NMR (
(3) 화합물 14의 합성 (3) Synthesis of
250 mL Schlenk 플라스크에 화합물 13 (2.27 mmol, 0.735 g)을 넣어준 후 THF 30 mL로 녹인 후에 드라이아이스/아세톤을 이용하여 -78℃로 낮춰주었다. 여기에 3 당량의 t-BuNH2 (6.81 mmol, 0.72 mL)를 주사기를 이용하여 천천히 가해준 뒤 서서히 상온으로 승온시켜 15 시간 동안 교반하였다. 진공 하에서 모든 용매를 제거한 뒤 n-Hexane으로 추출하였다. 혼합물을 Celite bed로 salt를 제거한 후에 진공 하에서 모든 용매를 제거하여 82.9 % (0.672 g)의 수율로 끈적한 노란색 오일의 화합물 14를 얻었다.Compound 13 (2.27 mmol, 0.735 g) was added to a 250 mL Schlenk flask, which was then dissolved in 30 mL of THF and then cooled to -78 ° C using dry ice / acetone. Three equivalents of t-BuNH 2 (6.81 mmol, 0.72 mL) was slowly added thereto using a syringe, and the temperature was gradually raised to room temperature, followed by stirring for 15 hours. All solvents were removed under vacuum and extracted with n-hexane. After removing the salt from the mixture with a Celite bed, all the solvent was removed under vacuum to obtain
화합물 14의 NMR 스펙트럼을 아래에 나타내었다 (도 24 및 도 25 참조).NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.23 (m, 2H, Ph), 7.14 (m, 2H, Ph), 3.53 (s, 1H, Cp(H)), 2.48 (s, 3H, SMe), 2.08 (s, 3H, Cp(CH3)3), 2.01 (d, 3H, J = 1.6 Hz, Cp(CH3)3), 1.89 (s, 3H, Cp(CH3)3), 0.98 (s, 9H, NC(CH3)3), 0.4 (s, 1H, NH), -0.19 (s, 3H, Si(CH3)2), -0.29 (s, 3H, Si(CH3)2). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.23 (m, 2H, Ph), 7.14 (m, 2H, Ph), 3.53 (s, 1H, Cp (H)), 2.48 (s, 3H, SMe), 2.08 (s, 3H , Cp (CH 3) 3), 2.01 (d, 3H, J = 1.6 Hz, Cp (CH 3) 3), 1.89 (s, 3H, Cp (CH 3) 3), 0.98 (s, 9H, NC ( CH 3) 3), 0.4 (s, 1H, NH), -0.19 (s, 3H, Si (CH 3) 2), -0.29 (s, 3H, Si (CH 3) 2 ).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 137.25, 136.96, 136.69, 136. 28, 135.81, 134.96, 129.55, 126.72 (Ph, Cp), 55.47 (NC), 49.17 (Cp), 33.48 (N(CH3)2), 16.29 Cp(CH3)3), 14.98 (SMe), 11.1, 12.52 (Cp(CH3)3), -0.069, 0.7 (Si(CH3)2). 13 C ( 1 H) NMR (CDCl 3 , 100.61 MHz, ppm):? 137.25, 136.96,136.69,136.88,135.81,134.96,129.55,126.72 (Ph, Cp), 55.47 , 33.48 (N (CH 3) 2), 16.29 Cp (CH 3) 3), 14.98 (SMe), 11.1, 12.52 (Cp (CH 3) 3), -0.069, 0.7 (Si (CH 3) 2).
(4) 화합물 15의 합성 (4) Synthesis of
250 mL Schlenk 플라스크에 화합물 14 (1.74 mmol, 0.628 g)를 넣어준 후 THF 30 mL로 녹여준 뒤 드라이아이스/아세톤을 이용하여 -78℃로 낮춰주었다. 2.1 당량의 n-BuLi (3.65 mmol, 1.46 mL)를 주사기로 천천히 가해준 후 서서히 상온으로 승온시켜 2 시간 동안 교반하였다. 2 시간 후에 미리 -78℃로 낮춘 0.98 당량의 TiCl3(THF)3 (1.71 mmol, 0.632 g)의 THF 슬러리로 리튬 음이온 용액을 캐뉼라를 이용하여 빠르게 가한다. 반응물을 서서히 상온으로 승온시켜 15시간동안 교반하였다. 혼합 용액을 1.1 당량의 AgCl (1.91 mmol, 0.274 g)이 담긴 250 mL Schlenk 플라스크로 빠르게 적가하여 1 시간 동안 더 교반해 주었다. 진공 하에서 모든 용매를 제거한 뒤 n-Hexane으로 추출한다. 혼합물을 Celite bed로 salt를 제거한 후에 진공 하에서 모든 용매를 제거하여 84.1 % (0.683 g)의 수율로 짙은 붉은색의 결정성 고체인 화합물 15를 얻었다.Compound 14 (1.74 mmol, 0.628 g) was added to a 250 mL Schlenk flask, dissolved in 30 mL of THF, and then cooled down to -78 ° C using dry ice / acetone. 2.1 equivalents of n-BuLi (3.65 mmol, 1.46 mL) was slowly added by syringe, then slowly warmed to room temperature and stirred for 2 hours. After 2 hours, the lithium anion solution was quickly added to the THF slurry of 0.98 equivalents of TiCl 3 (THF) 3 (1.71 mmol, 0.632 g) previously lowered to -78 ° C using a cannula. The reaction was slowly warmed to room temperature and stirred for 15 hours. The mixed solution was rapidly added dropwise to a 250 mL Schlenk flask containing 1.1 equivalents of AgCl (1.91 mmol, 0.274 g), and the mixture was further stirred for 1 hour. Remove all solvents under vacuum and extract with n-hexane. After removing the salt from the mixture with a Celite bed, all the solvent was removed under vacuum to obtain a dark red crystalline
화합물 15의 NMR 스펙트럼을 아래에 나타내었다 (도 26 및 도 27 참조).The NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.16 (d, 2H, J = 6.36 Hz, Ph), 2.48 (s, 3H, SMe), 2.27 (s, 3H, Cp(CH3)3), 2.21 (s, 3H, Cp(CH3)3), 2.13 (s, 3H, Cp(CH3)3), 1.36 (s, 9H, NC(CH3)3), 0.63 (s, 3H, Si(CH3)2), -0.14 (s, 3H, Si(CH3)2). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.16 (d, 2H, J = 6.36 Hz, Ph), 2.48 (s, 3H, SMe), 2.27 (s, 3H, Cp (CH 3) 3) , 2.21 (s, 3H, Cp (CH 3) 3), 2.13 (s, 3H, Cp (CH 3) 3), 1.36 (s, 9H, NC (CH 3) 3), 0.63 (s, 3H, Si (CH 3) 2), -0.14 (s, 3H, Si (CH 3) 2).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 147.23, 142.35, 138.84, 137.69, 137.1, 131.87, 125.24, 104.39 (Ph, Cp), 63.06 (NC), 32.56 (NC(CH3)2), 16.71 (SMe), 13.24, 13.26, 15.37 (Cp(CH3)3), 4.21, 4.87 (Si(CH3)2).
13 C {1 H} NMR (
실시예Example 4 4
도 28에 나타낸 Scheme에 따라 하기 화합물 19를 합성하였다. 이하, 각 화합물의 합성에 대하여 설명한다.The following
[화합물 19][Compound 19]
(1) 화합물 16의 합성 (1) Synthesis of Compound (16)
화합물 16은 화합물 12의 합성 경로와 같은 방법을 적용하여 얻었다. 2,3,4-trimethylcyclopent-2-enone (16.5 mmol, 2.05 g), 4-fluorophenylmagnesium bromide 용액 (15 mmol, 15 mL)을 사용하여 80.4 % (2.46 g)의 수율로 옅은 상아색의 고체인 화합물 16을 얻었다.
화합물 16의 NMR 스펙트럼을 아래에 나타내었다 (도 29, 도 30 및 도 31 참조).The NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.25 (m, 2H, Ph), 6.97 (m, 2H, Ph), 3.13 (t, 2H, J = 1.64 Hz, Cp(H2)), 2.02 (s, 3H, Cp(CH3)3), 1.97 (s, 3H, Cp(CH3)3), 1.85 (d, 3H, J = 0.8 Hz, Cp(CH3)3). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.25 (m, 2H, Ph), 6.97 (m, 2H, Ph), 3.13 (t, 2H, J = 1.64 Hz, Cp (H 2)), 2.02 (s, 3H, Cp ( CH 3) 3), 1.97 (s, 3H, Cp (CH 3) 3), 1.85 (d, 3H, J = 0.8 Hz, Cp (CH 3) 3).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 162.14, 159.7, 138.87, 138.86, 137.23, 135, 134.74, 134.2, 134.17, 128.86, 128.78, 115,12, 114.91 (Ph, Cp), 46.91 (Cp), 11.18, 12.95, 13.48 (Cp(CH3)3). 13 C ( 1 H) NMR (CDCl 3 , 100.61 MHz, ppm): δ 162.14, 159.7, 138.87, 138.86, 137.23, 135, 134.74, 134.2, 134.17, 128.86, 128.78, , 46.91 (Cp), 11.18, 12.95, 13.48 (Cp (CH 3) 3).
19F NMR (CDCl3, 376.5 MHz, ppm): δ -117.49. 19 F NMR (CDCl 3, 376.5 MHz, ppm): δ -117.49.
(2) 화합물 17의 합성 (2) Synthesis of
화합물 17은 화합물 13의 합성 경로와 같은 방법을 적용하여 얻었다. 화합물 16 (3.27 mmol, 0.661 g), 1.1당량의 n-BuLi (3.59 mmol, 1.44 mL) 및 2.5 당량의 Me2SiCl2 (8.18 mmol, 1.0 mL)를 사용하여 94.7 % (0.913 g)의 수율로 옅은 갈색의 오일인 화합물 17을 얻었다.
화합물 17의 NMR 스펙트럼을 아래에 나타내었다 (도 32, 도 33 및 도 34 참조).The NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.18 (m, 2H, Ph), 7.03 (m, 2H, Ph), 3.73 (s, 1H, Cp(H)), 2.16 (s, 3H, Cp(CH3)3), 2.04 (s, 3H, Cp(CH3)3), 1.94 (s, 3H, Cp(CH3)3), -0.03, (s, 3H, Si(CH3)2), -0.076 (s, 3H, Si(CH3)2). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.18 (m, 2H, Ph), 7.03 (m, 2H, Ph), 3.73 (s, 1H, Cp (H)), 2.16 (s, 3H, Cp (CH 3) 3), 2.04 (s, 3H, Cp (CH 3) 3), 1.94 (s, 3H, Cp (CH 3) 3), -0.03, (s, 3H, Si (CH 3) 2 ), -0.076 (s, 3H, Si (CH 3) 2).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 162.32, 160.37, 139.49, 137.77, 135.92, 134.05, 133.86, 130.41, 130.35, 115.14, 114.97 (Ph, Cp), 55.04 (Cp), 11.13, 12.57, 14.6 (Cp(CH3)3), 2.53 (Si(CH3)2), -2.19 (Si(CH3)2). 13 C ( 1 H) NMR (CDCl 3 , 100.61 MHz, ppm): δ 162.32, 160.37, 139.49, 137.77, 135.92, 134.05, 133.86, 130.41, 130.35, 115.14, 114.97 (Ph, Cp), 55.04 11.13, 12.57, 14.6 (Cp ( CH 3) 3), 2.53 (Si (CH 3) 2), -2.19 (Si (CH 3) 2).
19F NMR (CDCl3, 376.5 MHz, ppm): δ -117.39. 19 F NMR (CDCl 3, 376.5 MHz, ppm): δ -117.39.
(3) 화합물 18의 합성 (3) Synthesis of
화합물 18은 화합물 14의 합성 경로와 같은 방법을 적용하여 얻었다. 화합물 17 (3.04 mmol, 0.896 g), 3 당량의 t-BuNH2 (9.12 mmol, 0.96 mL)를 사용하여 98.3 % (0.987 g)의 수율로 갈색의 오일인 화합물 18을 얻었다.
화합물 18의 NMR 스펙트럼을 아래에 나타내었다 (도 35, 도 36 및 도 37 참조).The NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.17 (m, 2H, Ph), 7.02 (m, 2H, Ph), 3.52 (s, 1H, Cp(H)), 2.1 (s, 3H, Cp(CH3)3), 2.0 (s, 3H, Cp(CH3)3), 1.91 (s, 3H, Cp(CH3)3), 1.01 (s, 9H, NC(CH3)3), 0.29 (s, 1H, NH), -0.19, (s, 3H, Si(CH3)2), -0.27 (s, 3H, Si(CH3)2). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.17 (m, 2H, Ph), 7.02 (m, 2H, Ph), 3.52 (s, 1H, Cp (H)), 2.1 (s, 3H, Cp (CH 3) 3), 2.0 (s, 3H, Cp (CH 3) 3), 1.91 (s, 3H, Cp (CH 3) 3), 1.01 (s, 9H, NC (CH 3) 3), 0.29 (s, 1H, NH) , -0.19, (s, 3H, Si (CH 3) 2), -0.27 (s, 3H, Si (CH 3) 2).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 162.15, 160.2, 136.99, 136.85, 136.7, 135.77, 135.33, 135.3, 130.57, 130.51, 114.93, 114.76 (Ph, Cp), 55.79 (NC), 49.23 (Cp), 33.57 (NC(CH3)3), 11.14, 12.46, 15 (Cp(CH3)3), 0.85 (Si(CH3)2), -0.082 (Si(CH3)2). 13 C { 1 H} NMR (CDCl 3 , 100.61 MHz, ppm): δ 162.15, 160.2, 136.99, 136.85, 136.7, 135.77, 135.33, 135.3, 130.57, 130.51, 114.93, 114.76 (Ph, Cp), 55.79 ), 49.23 (Cp), 33.57 (NC (CH 3) 3), 11.14, 12.46, 15 (Cp (CH 3) 3), 0.85 (Si (CH 3) 2), -0.082 (Si (CH 3) 2 ).
19F NMR (CDCl3, 376.5 MHz, ppm): δ -116.14. 19 F NMR (CDCl 3, 376.5 MHz, ppm): δ -116.14.
(4) 화합물 19의 합성 (4) Synthesis of
화합물 19는 화합물 15의 합성 경로와 같은 방법을 적용하여 얻었다. 화합물 18 (2.96 mmol, 0.978 g), 2.1 당량의 n-BuLi (6.22 mmol, 2.5 mL), 0.98 당량의 TiCl3(THF)3 (2.9 mmol, 1.07 g), 및 1.1 당량의 AgCl (3.26 mmol, 0.466 g)을 사용하여 87.4 % (1.16 g)의 수율로 노란색을 띠는 갈색의 고체인 화합물 19를 얻었다.
화합물 19의 NMR 스펙트럼을 아래에 나타내었다 (도 38, 도 39 및 도 40).The NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 6.98 (m, 4H, Ph), 2.27 (s, 3H, Cp(CH3)3), 2.21 (s, 3H, Cp(CH3)3), 2.12 (s, 3H, Cp(CH3)3), 1.36 (s, 9H, NC(CH3)3), 0.64 (s, 3H, Si(CH3)2), -0.18 (s, 3H, Si(CH3)2). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 6.98 (m, 4H, Ph), 2.27 (s, 3H, Cp (CH 3) 3), 2.21 (s, 3H, Cp (CH 3) 3) , 2.12 (s, 3H, Cp (CH 3) 3), 1.36 (s, 9H, NC (CH 3) 3), 0.64 (s, 3H, Si (CH 3) 2), -0.18 (s, 3H, Si (CH 3) 2).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 163.63, 161.65, 146.47, 142.42, 137.64, 137.27, 131.29, 131.27, 114,78, 114.61, 104.53 (Ph, Cp), 63.13 (NC), 32.54 (NC(CH3)3), 13.23, 16.71 (Cp(CH3)3), 3.98, 4.83 (Si(CH3)2). 13 C { 1 H} NMR (CDCl 3 , 100.61 MHz, ppm): δ 163.63, 161.65, 146.47, 142.42, 137.64, 137.27, 131.29, 131.27, 114.78, 114.61, 104.53 (Ph, Cp), 63.13 ), 32.54 (NC (CH 3 ) 3), 13.23, 16.71 (Cp (CH 3) 3), 3.98, 4.83 (Si (CH 3) 2).
19F NMR (CDCl3, 376.5 MHz, ppm): δ -113.55.
19 F NMR (CDCl 3 , 376.5 MHz, ppm): 隆 -113.55.
실시예Example 5 5
도 41에 나타낸 Scheme에 따라 하기 화합물 23을 합성하였다. 이하, 각 화합물의 합성에 대하여 설명한다.The following
[화합물 23][Compound 23]
(1) 화합물 20의 합성 (1) Synthesis of
화합물 20은 화합물 12의 합성 경로와 같은 방법을 적용하여 얻였다. 2,3,4-trimethylcyclopent-2-enone (16.5 mmol, 2.05 g), 2-thienylmagnesium bromide 용액 (15 mmol, 15 mL)을 사용하여 92.9% (2.65 g)의 수율로 옅은 상아색의 고체인 화합물 20을 얻었다.
화합물 20의 NMR 스펙트럼을 아래에 나타내었다 (도 42 및 도 43 참조).The NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.13 (q, 1H, J = 2.07 Hz, Th), 6.99 (q, 1H, J = 2.91 Hz, Th), 6.95 (q, 1H, J = 1.45 Hz, Th), 3.22 (q, 2H, J = 1.71 Hz, Cp(H2)), 2.12 (t, 3H, J = 1.76 Hz, Cp(CH3)3), 1.97 (s, 3H, Cp(CH3)3), 1.84 (q, 3H, J = 1.49 Hz, Cp(CH3)3). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.13 (q, 1H, J = 2.07 Hz, Th), 6.99 (q, 1H, J = 2.91 Hz, Th), 6.95 (q, 1H, J = 1.45 Hz, Th), 3.22 ( q, 2H, J = 1.71 Hz, Cp (H 2)), 2.12 (t, 3H, J = 1.76 Hz, Cp (CH 3) 3), 1.97 (s, 3H, Cp (CH 3) 3), 1.84 (q, 3H, J = 1.49 Hz, Cp (CH 3) 3).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 141.27, 139.01, 137.35, 134.45, 129.62, 127.01, 122.28, 122.11, 46.91 (Ph, Cp), 13.55, 13.29, 11.14 (Cp(CH3)3). 13 C ( 1 H) NMR (CDCl 3 , 100.61 MHz, ppm):? 141.27,139.01,137.35,134.45,129.62,127.01,122.28,121.11,46.91 (Ph, Cp), 13.55,13.29,11.14 3 ) 3 ).
(2) 화합물 21의 합성 (2) Synthesis of
화합물 21은 화합물 13의 합성 경로와 같은 방법을 적용하여 얻었다. 화합물 20 (10.0 mmol, 1.9 g), 1.1 당량의 n-BuLi (11.0 mmol, 4.4 mL) 및 2.5 당량의 Me2SiCl2 (25.0 mmol, 3.0 mL) 사용하여 99.3% (2.81 g)의 수율로 옅은 오렌지색의 오일인 화합물 21을 얻었다.
화합물 21의 NMR 스펙트럼을 아래에 나타내었다 (도 44 및 도 45 참조).The NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.21 (q, 1H, J = 1.65 Hz, Th), 7.01 (q, 1H, J = 2.64 Hz, Th), 6.84 (t, 1H, J = 1.38 Hz, Th), 3.7 (s, 1H, Cp(H)), 2.14 (s, 3H, Cp(CH3)3), 2.12 (s, 3H, Cp(CH3)3), 1.91 (s, 3H, Cp(CH3)3), 0.059, (s, 3H, Si(CH3)2), -0.056 (s, 3H, Si(CH3)2). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.21 (q, 1H, J = 1.65 Hz, Th), 7.01 (q, 1H, J = 2.64 Hz, Th), 6.84 (t, 1H, J = 1.38 Hz, Th), 3.7 ( s, 1H, Cp (H)), 2.14 (s, 3H, Cp (CH 3) 3), 2.12 (s, 3H, Cp (CH 3) 3), 1.91 (s, 3H, Cp (CH 3) 3 ), 0.059, (s, 3H, Si (CH 3) 2), -0.056 (s, 3H, Si (CH 3) 2).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 140.29, 140.17, 137.93, 136.62, 128.22, 127.03, 124.82, 123.87, 56.21 (Ph, Cp), 14.68, 12.84, 11.09 (Cp(CH3)3), 2.4 (Si(CH3)2), -2.53 (Si(CH3)2). 13 C { 1 H} NMR (CDCl 3 , 100.61 MHz, ppm): δ 140.29, 140.17, 137.93, 136.62, 128.22, 127.03, 124.82, 123.87, 56.21 (Ph, Cp), 14.68, 12.84, 3 ) 3 , 2.4 (Si (CH 3 ) 2 ), and -2.53 (Si (CH 3 ) 2 ).
(3) 화합물 22의 합성 (3) Synthesis of
화합물 22는 화합물 14의 합성 경로와 같은 방법을 적용하여 얻었다. 화합물 21 (6.0 mmol, 1.7 g), 3 당량의 t-BuNH2 (18.0 mmol, 1.9 mL)을 사용하여 92.9% (1.78 g)의 수율로 끈적한 옅은 오렌지색의 오일인 화합물 22를 얻었다.
화합물 22의 NMR 스펙트럼을 아래에 나타내었다 (도 46 및 도 47 참조).The NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.18 (d, 1H, J = 3.32 Hz, Th), 7.01 (q, 1H, J = 2.29 Hz, Th), 6.82 (s, br, 1H, Th), 3.51 (s, 1H, Cp(H)), 2.11 (s, 3H, Cp(CH3)3), 2.09 (s, 3H, Cp(CH3)3), 1.9 (s, 3H, Cp(CH3)3), 1.07 (s, 9H, NC(CH3)3), -0.16, (s, 3H, Si(CH3)2), -0.19 (s, 3H, Si(CH3)2). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.18 (d, 1H, J = 3.32 Hz, Th), 7.01 (q, 1H, J = 2.29 Hz, Th), 6.82 (s, br, 1H, Th), 3.51 (s, 1H , Cp (H)), 2.11 (s, 3H, Cp (CH 3) 3), 2.09 (s, 3H, Cp (CH 3) 3), 1.9 (s, 3H, Cp (CH 3) 3), 1.07 (s, 9H, NC (CH 3) 3), -0.16, (s, 3H, Si (CH 3) 2), -0.19 (s, 3H, Si (CH 3) 2 ).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 141.86, 138.01, 137.44, 135.94, 130.81, 126.89, 124.33, 123.24 (Ph, Cp), 57.11 (NC), 49.31 (Cp), 33.63 (NC(CH3)3), 15.05, 12.76, 11.1 (Cp(CH3)3), 0.7 (Si(CH3)2), -0.56 (Si(CH3)2). 13 C ( 1 H) NMR (CDCl 3 , 100.61 MHz, ppm): δ 141.86, 138.01, 137.44, 135.94, 130.81, 126.89, 124.33, 123.24 (Ph, Cp), 57.11 (NC (CH 3) 3) , 15.05, 12.76, 11.1 (Cp (CH 3) 3), 0.7 (Si (CH 3) 2), -0.56 (Si (CH 3) 2).
(4) 화합물 23의 합성 (4) Synthesis of
화합물 23은 화합물 15의 합성 경로와 같은 방법을 적용하여 얻었다. 화합물 22 (5.0 mmol, 1.6 g), 2.1 당량의 n-BuLi (10.5 mmol, 4.2 mL), 0.98 당량의 TiCl3(THF)3 (4.9 mmol, 1.82 g), 및 1.1 당량의 AgCl (5.39 mmol, 0.772 g)을 사용하여 69.4% (1.51 g)의 수율로 진한 붉은 크리스탈의 고체인 화합물 23을 얻었다.
화합물 23의 NMR 스펙트럼을 아래에 나타내었다 (도 48 및 도 49 참조).The NMR spectrum of
1H NMR (CDCl3, 400.13 MHz, ppm): δ 7.16 (d, 1H, J = 3.4 Hz, Th), 6.98 (q, 1H, J = 2.31 Hz, Th), 6.78 (d, 1H, J = 2.08 Hz, Th), 2.07 (s, 3H, Cp(CH3)3), 2.05 (s, 3H, Cp(CH3)3), 1.86 (s, 3H, Cp(CH3)3), 1.03 (s, 9H, NC(CH3)3), -0.21 (s, 3H, Si(CH3)2), -0.23 (s, 3H, Si(CH3)2). 1 H NMR (CDCl 3, 400.13 MHz, ppm): δ 7.16 (d, 1H, J = 3.4 Hz, Th), 6.98 (q, 1H, J = 2.31 Hz, Th), 6.78 (d, 1H, J = 2.08 Hz, Th), 2.07 ( s, 3H, Cp (CH 3) 3), 2.05 (s, 3H, Cp (CH 3) 3), 1.86 (s, 3H, Cp (CH 3) 3), 1.03 ( s, 9H, NC (CH 3 ) 3), -0.21 (s, 3H, Si (CH 3) 2), -0.23 (s, 3H, Si (CH 3) 2).
13C{1H} NMR (CDCl3, 100.61 MHz, ppm): δ 141.73, 137.88, 137.33, 135.82, 130.72, 126.8, 124.22, 123.14 (Ph, Cp), 57 (NC), 33.54 (NC(CH3)3), 14.97, 12.68, 11.02 (Cp(CH3)3), 0.61, -0.68 (Si(CH3)2).
13 C {1H} NMR (CDCl 3, 100.61 MHz, ppm): δ 141.73, 137.88, 137.33, 135.82, 130.72, 126.8, 124.22, 123.14 (Ph, Cp), 57 (NC), 33.54 (NC (CH 3) 3), 14.97, 12.68, 11.02 (Cp (CH 3) 3), 0.61, -0.68 (Si (CH 3) 2).
시험예Test Example
비교예 및 실시예에 따른 각각의 최종 화합물을 촉매로 이용하여 에틸렌/1-옥텐 공중합 및 에틸렌/1-헥산 공중합을 실시하였다.Ethylene / 1-octene copolymerization and ethylene / 1-hexane copolymerization were carried out using each of the final compounds according to the Comparative Examples and Examples as catalysts.
구체적으로, 250mL Schlenk 플라스크에 적정량의 s-MAO를 준비하고 정제된 toluene (49.5 mL)을 캐뉼라를 통해 넣었다. 일정시간 동안 중합온도 하에서 교반하고, 적정량의 1-octene (혹은 1-hexene)을 적가하고 에틸렌 단량체를 1 bar에서 약 3분간 포화시켜주었다. 3분간의 에틸렌 단량체 포화가 끝나면 0.5 mL의 톨루엔에 녹인 적정량의 촉매를 넣어 반응을 개시하였다. 반응이 경과함에 따라 용액의 점도가 증가하는 것을 확인 할 수 있었고, 준비된 10 % HCl/MeOH 용액 약 2 mL를 주사기로 넣어 반응을 종결시켰다. 10 % HCl/MeOH 용액에 종결시킨 혼합물을 부어주었다. 얻어진 고분자는 종이 여과를 하고, MeOH로 여러 번 씻어주었다. 여과된 고분자를 약 60 ℃의 진공 오븐에서 10시간 이상 건조하여 최종 공중합체를 얻을 수 있었다.Specifically, an appropriate amount of s-MAO was prepared in a 250 mL Schlenk flask and purified toluene (49.5 mL) was introduced through a cannula. The mixture was stirred at a polymerization temperature for a certain period of time, an appropriate amount of 1-octene (or 1-hexene) was added dropwise, and the ethylene monomer was saturated at 1 bar for about 3 minutes. After 3 minutes of ethylene monomer saturation, the reaction was initiated by adding a proper amount of catalyst dissolved in 0.5 mL of toluene. As the reaction progressed, the viscosity of the solution increased, and about 2 mL of the prepared 10% HCl / MeOH solution was added to the syringe to terminate the reaction. The mixture was poured into a 10% HCl / MeOH solution. The obtained polymer was subjected to paper filtration and washed several times with MeOH. The filtered polymer was dried in a vacuum oven at about 60 DEG C for at least 10 hours to obtain a final copolymer.
그리고, 각각의 공정에 따른 공중합체의 물성 측정 결과를 하기 표 1 및 표 2에 나타내었다.
The measurement results of the physical properties of the copolymer according to the respective steps are shown in Tables 1 and 2 below.
(1) 에틸렌/1-옥텐 공중합(1) Ethylene / 1-octene copolymerization
1Comparative Example
One
2Comparative Example
2
1Example
One
2Example
2
3Example
3
4Example
4
5Example
5
(kg/mol*h)Activity
(kg / mol * h)
contents
(mol%) b Comonomer
contents
(mol%) b
a Copolymerization condition: [Cat] = 1 μmol(비교예 1, 비교예 2); [Cat] = 5 μmol(실시예 1 내지 5); [MAO]/[Cat] = 2000; toluene = 50 mL; Time = 15 min; Temp. = 75 ℃; Induction period = 45 min(실시예 1, 실시예 2), 15 min(실시예 3 내지 5) a Copolymerization condition: [Cat] = 1 μmol (Comparative Example 1, Comparative Example 2); [Cat] = 5 占 퐉 ol (Examples 1 to 5); [MAO] / [Cat] = 2000; toluene = 50 mL; Time = 15 min; Temp. = 75 DEG C; Induction period = 45 min (Examples 1 and 2), 15 min (Examples 3 to 5)
b Determined by 1H NMR b Determined by 1 H NMR
c Obtained by GPC analysis and calibrated by polystyrene standard
c Obtained by GPC analysis and calibrated by polystyrene standard
비교예 1 (1 μmol)을 촉매로 얻어진 고분자의 경우 탄성력을 띄는 투명한 고체 형태이고 3분간의 중합시간동안 수득량은 1.23 g이고 활성도는 4920 (kg/molh)를 보였으며 NMR 을 통해 1-octene 몰분율이 12.7 %로 얻어졌다. 그리고, 비교예 2(1 μmol)를 촉매로 얻어진 고분자는 가루형태인 무색의 고체로 얻어졌고 수득량은 1.06 g이고 활성도는 4240 (kg/molh)를 보였으며 얻어진 고분자의 형태로 알 수 있듯이 4.45 %의 낮은 1-octene 몰분율로 얻어졌다.The polymer obtained by the catalyst of Comparative Example 1 (1 μmol) was in the form of a transparent solid having elasticity, and the yield was 1.23 g and the activity was 4920 (kg / molh) over a polymerization time of 3 minutes. The mole fraction was obtained as 12.7%. The polymer obtained in Comparative Example 2 (1 μmol) as a catalyst was obtained as a colorless solid in powder form. The yield was 1.06 g and the activity was 4240 (kg / mol). As can be seen from the obtained polymer, % Of 1-octene mole fraction.
한편, 실시예 1 (5 μmol)을 촉매로 얻어진 고분자는 무색의 찢어지는 고무 형태로 얻어졌고 수득량은 1.88 g이고 활성도는 1500 (kg/molh) 를 보였으며 1-octene 몰분율이 11.2 %로 얻어졌다. 그리고, 실시예 2 (5 μmol)를 촉매로 얻어진 고분자는 가루형태인 무색의 고체로 얻어졌고 수득량은 0.2 g이고 활성도는 160 (kg/molh)를 보였으며 1-octene 몰분율이 17.9 %로 얻어졌다.On the other hand, the polymer obtained in Example 1 (5 μmol) was obtained in the form of a colorless tear rubber. The yield was 1.88 g, the activity was 1500 kg / molh and the molar fraction of 1-octene was 11.2% lost. The polymer obtained in Example 2 (5 μmol) as a catalyst was obtained as a colorless solid in the form of powder, the yield was 0.2 g, the activity was 160 kg / molh and the mole fraction of 1-octene was 17.9% lost.
비교예 1 및 비교예 2는 상대적으로 높은 활성도를 나타냄에도 불구하고 실시예 1 또는 실시예 2에 비해 상대적으로 낮은 1-octene 몰분율 혹은 분자량을 나타내었다. 특히, 비교예 2는 ethylene/1-octene의 공중합에 있어서 적당한 촉매계가 아님을 확인하였다. 또한, 실시예 1 또는 실시예 2는 활성도는 상대적으로 낮았으나 높은 1-octene 몰분율 혹은 분자량의 공중합체가 얻어짐을 확인함으로써 ethylene/1-octene의 공중합에 있어서 유용한 촉매계로 쓰일 수 있음을 확인하였다.Comparative Example 1 and Comparative Example 2 exhibited a relatively low 1-octene molar fraction or molecular weight as compared with Example 1 or Example 2, although they exhibited relatively high activity. In particular, it was confirmed that Comparative Example 2 is not a suitable catalyst system in the copolymerization of ethylene / 1-octene. In addition, the activity of Example 1 or Example 2 was relatively low, but it was confirmed that a copolymer having a high mole fraction of 1-octene or a molecular weight could be obtained, and thus it could be used as a catalyst system for ethylene / 1-octene copolymerization.
특히, 실시예 1과 실시예 2의 촉매가 적용된 중합 공정에서는 비교예 1 및 비교예 2의 촉매가 적용된 중합 공정에 비하여 적게는 3 배, 많게는 7 배 이상 넓은 분자량 분포를 갖는 공중합체를 얻을 수 있었다.Particularly, in the polymerization process using the catalysts of Examples 1 and 2, a copolymer having a molecular weight distribution that is at least three times and at least seven times greater than that of the catalysts of Comparative Example 1 and Comparative Example 2 is obtained there was.
또한, 실시예 1의 촉매를 이용한 경우 중량평균분자량이 큰 공중합체를 얻을 수 있었다. 특히, 실시예 2의 촉매는 다른 화합물들에 비하여 보다 향상된 공단량체 삽입능을 가져, 이를 이용하여 얻어지는 공중합체는 중량평균분자량이 크면서도 공단량체 함량이 월등히 높게 나타났다.
Further, when the catalyst of Example 1 was used, a copolymer having a large weight average molecular weight could be obtained. In particular, the catalyst of Example 2 has improved comonomer incorporation ability as compared with other compounds, and the copolymer obtained using the same has a high weight average molecular weight and a significantly higher comonomer content.
(2) 에틸렌/1-헥센 공중합(2) Ethylene / 1-hexene copolymerization
1Comparative Example
One
1Example
One
2Example
2
3Example
3
4Example
4
5Example
5
(kg/mol*h)Activity
(kg / mol * h)
contents
(mol%) b Comonomer
contents
(mol%) b
a Copolymerization condition: [Cat] = 1 μmol(비교예 1); [Cat] = 5 μmol(실시예 1 내지 5); [MAO]/[Cat] = 2000; toluene = 50 mL; Time = 15 min; Temp. = 75 ℃; Induction period = 45 min(실시예 1, 실시예 2), 15 min(실시예 3 내지 5) a Copolymerization condition: [Cat] = 1 μmol (Comparative Example 1); [Cat] = 5 占 퐉 ol (Examples 1 to 5); [MAO] / [Cat] = 2000; toluene = 50 mL; Time = 15 min; Temp. = 75 DEG C; Induction period = 45 min (Examples 1 and 2), 15 min (Examples 3 to 5)
b Determined by 1H NMR b Determined by 1 H NMR
c Obtained by GPC analysis and calibrated by polystyrene standard
c Obtained by GPC analysis and calibrated by polystyrene standard
표 2를 통해 알 수 있는 바와 같이, 특히 실시예 4 및 실시예 5의 촉매를 이용한 경우 상대적으로 높은 1-hexene 몰분율을 나타내었다. 또한, 실시예 4의 촉매는 다른 실시예들의 촉매에 비하여 활성도가 2 내지 4 배 높게 나타났다. 그리고, 실시예 4 및 실시예 5의 촉매는 비교예 1의 촉매에 비하여 상대적으로 ?은 활성도를 가짐에도 불구하고, 더 높은 1-hexene 몰분율의 공중합체가 얻어짐을 확인하였다.
As can be seen from Table 2, the catalysts of Examples 4 and 5 showed relatively high 1-hexene mole fractions. In addition, the catalyst of Example 4 showed 2-4 times higher activity than the catalyst of the other Examples. It was confirmed that although the catalysts of Examples 4 and 5 have relatively higher silver activity than the catalyst of Comparative Example 1, higher copolymers of 1-hexene mole fractions were obtained.
Claims (9)
[화학식 1]
상기 화학식 1에서,
M은 4족 전이금속이고;
Q1 및 Q2는 각각 독립적으로 할로겐, 탄소수 1 내지 20의 알킬, 탄소수 2 내지 10의 알케닐, 탄소수 7 내지 40의 알킬아릴, 탄소수 7 내지 40의 아릴알킬, 탄소수 6 내지 20의 알릴, 탄소수 1 내지 20의 알킬리덴, 탄소수 2 내지 20의 알킬알콕시, 또는 탄소수 7 내지 40의 아릴알콕시이고;
R1, R2 및 R3 은 각각 독립적으로 수소, 탄소수 1 내지 20의 알킬, 탄소수 1 내지 10의 알콕시, 탄소수 6 내지 20의 아릴, 탄소수 6 내지 10의 아릴옥시, 탄소수 2 내지 20의 알케닐, 탄소수 7 내지 40의 알킬아릴, 탄소수 7 내지 40의 아릴알킬, 탄소수 8 내지 40의 아릴알케닐, 또는 탄소수 2 내지 10의 알키닐이고; 상기 R1 및 R2 또는 R2 및 R3 서로 연결되어 고리를 형성할 수 있고;
A는 하기 화학식 2로 표시되는 군에서 선택된 어느 하나의 치환기이다 (단, 하기 화학식 2에서 '*' 표시 부분은 A와 사이클로펜타디에닐 리간드의 연결부임).
[화학식 2]
1. A catalyst for olefin polymerization comprising a transition metal compound represented by the following formula
[Chemical Formula 1]
In Formula 1,
M is a Group 4 transition metal;
Q 1 and Q 2 are each independently selected from the group consisting of halogen, alkyl of 1 to 20 carbon atoms, alkenyl of 2 to 10 carbon atoms, alkylaryl of 7 to 40 carbon atoms, arylalkyl of 7 to 40 carbon atoms, allyl of 6 to 20 carbon atoms, Alkylidene of 1 to 20 carbon atoms, alkylalkoxy of 2 to 20 carbon atoms, or arylalkoxy of 7 to 40 carbon atoms;
R 1 , R 2 and R 3 are each independently selected from the group consisting of hydrogen, alkyl of 1 to 20 carbon atoms, alkoxy of 1 to 10 carbon atoms, aryl of 6 to 20 carbon atoms, aryloxy of 6 to 10 carbon atoms, , Alkylaryl having 7 to 40 carbon atoms, arylalkyl having 7 to 40 carbon atoms, arylalkenyl having 8 to 40 carbon atoms, or alkynyl having 2 to 10 carbon atoms; R 1 and R 2 or R 2 and R 3 may be connected to each other to form a ring;
A is any one substituent selected from the group consisting of a group represented by the following formula (2), provided that the symbol "*" in the following formula (2) is a linkage of A and a cyclopentadienyl ligand.
(2)
상기 M은 티타늄(Ti), 지르코늄(Zr) 또는 하프늄(Hf)이고;
상기 Q1 및 Q2 는 각각 독립적으로 메틸 또는 염소이고;
상기 R1, R2 및 R3 는 각각 독립적으로 수소 또는 메틸인 올레핀 중합용 촉매.
The method according to claim 1,
M is titanium (Ti), zirconium (Zr) or hafnium (Hf);
The Q 1 and Q 2 Are each independently methyl or chlorine;
Wherein R 1 , R 2 and R 3 are each independently hydrogen or methyl.
하기 화학식 3, 화학식 4 및 화학식 5로 표시되는 군에서 선택되는 1종 이상의 조촉매 화합물을 더욱 포함하는 올레핀 중합용 촉매:
[화학식 3]
-[Al(R31)-O]a-
상기 화학식 3에서,
R31은 각각 독립적으로 수소, 할로겐 라디칼, 탄소수 1 내지 20의 하이드로카르빌 라디칼 또는 할로겐으로 치환된 탄소수 1 내지 20의 하이드로카르빌 라디칼이며;
a는 2 이상의 정수이다;
[화학식 4]
D(R41)3
상기 화학식 4에서,
D는 알루미늄 또는 보론이며;
R41은 각각 독립적으로 할로겐 라디칼, 탄소수 1 내지 20의 하이드로카르빌 라디칼 또는 할로겐으로 치환된 탄소수 1 내지 20의 하이드로카르빌 라디칼이다.
[화학식 5]
[L-H]+[Z(A)4]- 또는 [L]+[Z(A)4]-
상기 화학식 5에서,
L은 중성 또는 양이온성 루이스 염기이고;
[L-H]+ 또는 [L]+ 는 브론스테드 산이고;
H는 수소 원자이고;
Z는 13족 원소이고;
A는 각각 독립적으로 1 이상의 수소 원자가 할로겐, 탄소수 1 내지 20의 하이드로카르빌, 탄소수 1 내지 20의 알콕시 또는 탄소수 6 내지 20의 아릴옥시 라디칼로 치환된 탄소수 6 내지 20의 아릴 또는 탄소수 1 내지 20의 알킬 라디칼이다.
The method according to claim 1,
A catalyst for olefin polymerization further comprising at least one promoter compound selected from the group consisting of the following chemical formulas (3), (4) and (5)
(3)
- [Al (R 31 ) -O] a -
In Formula 3,
R 31 is each independently a hydrogen, a halogen radical, a hydrocarbyl radical having 1 to 20 carbon atoms or a hydrocarbyl radical having 1 to 20 carbon atoms substituted with halogen;
a is an integer of 2 or more;
[Chemical Formula 4]
D (R < 41 > ) 3
In Formula 4,
D is aluminum or boron;
R 41 is each independently a halogen radical, a hydrocarbyl radical having 1 to 20 carbon atoms or a hydrocarbyl radical having 1 to 20 carbon atoms substituted with halogen.
[Chemical Formula 5]
[LH] + [Z (A ) 4] - or [L] + [Z (A ) 4] -
In Formula 5,
L is a neutral or cationic Lewis base;
[LH] + or [L] + is a Bronsted acid;
H is a hydrogen atom;
Z is a Group 13 element;
A is independently selected from the group consisting of a hydrogen atom, a halogen atom, a hydrocarbyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryloxy group having 6 to 20 carbon atoms, an aryl group having 6 to 20 carbon atoms, Alkyl radical.
상기 화학식 3의 R31은 메틸, 에틸, n-부틸 또는 이소부틸이고;
상기 화학식 4의 D는 알루미늄, R41은 메틸 또는 이소부틸이고; 또는 D는 보론, R41은 펜타플루오로페닐이며;
상기 화학식 5에서 [L-H]+는 디메틸아닐리늄 양이온이고; [Z(A)4]-는 [B(C6F5)4]-이고; [L]+는 [(C6H5)3C]+인 올레핀 중합용 촉매.
The method of claim 3,
R 31 in Formula 3 is methyl, ethyl, n-butyl or isobutyl;
D in the formula 4 is aluminum, R 41 is methyl or isobutyl; Or D is boron and R < 41 > is pentafluorophenyl;
[LH] + in the above formula (5) is a dimethylanilinium cation; [Z (A) 4 ] - is [B (C 6 F 5 ) 4 ] - ; [L] + is a catalyst for the polymerization of [(C 6 H 5 ) 3 C] + .
상기 조촉매 화합물의 함량은 상기 화학식 1로 표시되는 전이금속 화합물에 함유된 전이금속 1몰에 대하여 조촉매 화합물에 함유된 금속의 몰비를 기준으로 1:1 내지 1:100,000인 올레핀 중합용 촉매.
The method according to claim 1,
Wherein the content of the co-catalyst compound is 1: 1 to 1: 100,000 based on the molar ratio of the metal contained in the co-catalyst compound to one mole of the transition metal contained in the transition metal compound represented by the formula (1).
상기 화학식 1로 표시되는 전이금속 화합물이 담지되는 불활성 담체를 더욱 포함하는 올레핀 중합용 촉매.
The method according to claim 1,
A catalyst for olefin polymerization, further comprising an inert carrier on which the transition metal compound represented by Formula (1) is supported.
A process for producing a polyolefin comprising polymerizing at least one olefin-based monomer in the presence of the catalyst according to claim 1.
상기 올레핀계 단량체는 탄소수 2 내지 20의 알파-올레핀(α-olefin), 탄소수 1 내지 20의 디올레핀(diolefin), 탄소수 3 내지 20의 사이클로올레핀(cyclo-olefin) 또는 탄소수 3 내지 20의 사이클로디올레핀(cyclo-diolefin)으로 이루어진 군에서 선택된 1종 이상의 화합물인 폴리올레핀의 제조 방법.
8. The method of claim 7,
The olefinic monomer may be an α-olefin having 2 to 20 carbon atoms, a diolefin having 1 to 20 carbon atoms, a cyclo-olefin having 3 to 20 carbon atoms, Olefins. ≪ RTI ID = 0.0 > 21. < / RTI >
상기 폴리올레핀은 중량평균분자량(Mw)이 40,000 내지 1,000,000이고, 분자량 분포(Mw/Mn)가 2 내지 30인 폴리올레핀의 제조 방법.
8. The method of claim 7,
Wherein the polyolefin has a weight average molecular weight (Mw) of 40,000 to 1,000,000 and a molecular weight distribution (Mw / Mn) of 2 to 30.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020130037463 | 2013-04-05 | ||
KR20130037463 | 2013-04-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140121344A true KR20140121344A (en) | 2014-10-15 |
KR101599011B1 KR101599011B1 (en) | 2016-03-03 |
Family
ID=51992939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140034293A KR101599011B1 (en) | 2013-04-05 | 2014-03-24 | Catalyst for olefin polymerization and method for preparing polyolefin using the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101599011B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018106029A1 (en) * | 2016-12-06 | 2018-06-14 | 한화케미칼 주식회사 | Transition metal compound for olefin polymerization catalyst, olefin polymerization catalyst comprising same, and polyolefin polymerized using same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050028664A (en) * | 2003-09-19 | 2005-03-23 | 주식회사 엘지화학 | Metallocene catalyst, method for preparing the same and method of olefin polymerization using the catalyst |
KR20070029565A (en) * | 2005-09-09 | 2007-03-14 | 에스케이 주식회사 | HOMOGENEOUS CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR ETHYLENE COPOLYMERS WITH alpha;-OLEFINS |
KR20110133156A (en) * | 2010-06-04 | 2011-12-12 | 에스케이이노베이션 주식회사 | ADVANCED TRANSITION METAL CATALYTIC SYSTEMS IN TERMS OF COMONOMER INCORPORATIONS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND α-OLEFINS USING THE SAME |
KR20120076156A (en) * | 2010-12-29 | 2012-07-09 | 주식회사 엘지화학 | Method for preparing supported hybrid metallocene catalyst, and supported hybrid metallocene catalyst using the same |
-
2014
- 2014-03-24 KR KR1020140034293A patent/KR101599011B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050028664A (en) * | 2003-09-19 | 2005-03-23 | 주식회사 엘지화학 | Metallocene catalyst, method for preparing the same and method of olefin polymerization using the catalyst |
KR20070029565A (en) * | 2005-09-09 | 2007-03-14 | 에스케이 주식회사 | HOMOGENEOUS CATALYST SYSTEM FOR PRODUCING ETHYLENE HOMOPOLYMER OR ETHYLENE COPOLYMERS WITH alpha;-OLEFINS |
KR20110133156A (en) * | 2010-06-04 | 2011-12-12 | 에스케이이노베이션 주식회사 | ADVANCED TRANSITION METAL CATALYTIC SYSTEMS IN TERMS OF COMONOMER INCORPORATIONS AND METHODS FOR PREPARING ETHYLENE HOMOPOLYMERS OR COPOLYMERS OF ETHYLENE AND α-OLEFINS USING THE SAME |
KR20120076156A (en) * | 2010-12-29 | 2012-07-09 | 주식회사 엘지화학 | Method for preparing supported hybrid metallocene catalyst, and supported hybrid metallocene catalyst using the same |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018106029A1 (en) * | 2016-12-06 | 2018-06-14 | 한화케미칼 주식회사 | Transition metal compound for olefin polymerization catalyst, olefin polymerization catalyst comprising same, and polyolefin polymerized using same |
KR20180064731A (en) * | 2016-12-06 | 2018-06-15 | 한화케미칼 주식회사 | Transition metal compound used to prepare catalyst for polymerizing olefin, catalyst for polymerizing olefin comprising the same and polyolefin polymerized by using the same |
Also Published As
Publication number | Publication date |
---|---|
KR101599011B1 (en) | 2016-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101824638B1 (en) | Metallocene compound | |
KR101637026B1 (en) | Metallocene supported catalyst and method for preparing polyolefin using the same | |
KR101384401B1 (en) | Supported catalyst for olefin polymerization and process for preparing polyolefin using the same | |
EP2492291B1 (en) | Method for preparing a metallocene-supported catalyst, and metallocene-supported catalyst prepared by the method | |
KR101769097B1 (en) | Metallocene compound, catalyst composition comprising the same, and method for preparing polyolefin using the same | |
RU2529020C2 (en) | Novel metallocene compound, catalytic composition containing thereof and method of obtaining olifin-based polymers with its application | |
KR101691626B1 (en) | Metallocene compound, catalyst composition comprising the same, and method for preparation of olefin-based polymer using the same | |
EP2457894B1 (en) | Novel post metallocene-type transition metal compound | |
KR101760494B1 (en) | Metallocene supported catalyst and method for preparing polyolefin using the same | |
WO2017131490A2 (en) | Hybrid supported catalyst and method for preparing olefin polymer by using same | |
KR101600583B1 (en) | Dinuclear metallocene compound, and method for preparing the same | |
KR101663797B1 (en) | Metallocene compound, catalyst composition comprising the same, and method for preparing polyolefin using the same | |
EP3219719B1 (en) | Transition metal compound and catalyst composition containing same | |
KR101599011B1 (en) | Catalyst for olefin polymerization and method for preparing polyolefin using the same | |
KR101617871B1 (en) | Dinuclear metallocene compound, catalyst composition and method for preparing polyolefin using the same | |
CN113039190B (en) | Transition metal compound and catalyst composition comprising the same | |
KR101785705B1 (en) | Catalyst composition and method for preparing polyolefin using the same | |
KR102036664B1 (en) | Mixed catalytic composition comprising two transition metal compounds and method of preparing olefin-based copolymer using the same | |
KR101727701B1 (en) | Dinuclear metallocene compound, and method for preparing the same | |
KR101778762B1 (en) | Metallocene compound, catalyst composition comprising the same, and method for preparing olefin-based polymer using the same | |
KR101949456B1 (en) | Method for preparing supported hybrid metallocene catalyst, and supported hybrid metallocene catalyst using the same | |
KR20240079012A (en) | Propylene copolymer prepared by using asymmetric dinuclear metallocene supported catalyst | |
KR20160064570A (en) | Manufacturing method of ethylene polymers and ethylene polymers manufactured therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20190102 Year of fee payment: 4 |